{"idB": "1316175_12_item7_p4_s0", "idA": "1316175_11_item7_p12_s1", "sentA": "We expect to incur substantial clinical development costs for our Phase 3 clinical study named VISTA- 16 for varespladib and for our Phase 2b clinical study named PEARL-SC for A-623, as well as for the development of our other product candidates.", "sentB": "On March 9, 2012, an independent data safety monitoring board (DSMB) recommended stopping the Company's VISTA-16 clinical study for varespladib.", "type": 1, "words": ["<tag1>", "We", "expect", "to", "incur", "substantial", "clinical", "development", "costs", "for", "our", "Phase", "3", "clinical", "study", "named", "VISTA-", "16", "for", "varespladib", "and", "for", "our", "Phase", "2b", "clinical", "study", "named", "PEARL-SC", "for", "A-623,", "as", "well", "as", "for", "the", "development", "of", "our", "other", "product", "candidates.", "<tag2>", "On", "March", "9,", "2012,", "an", "independent", "data", "safety", "monitoring", "board", "(DSMB)", "recommended", "stopping", "the", "Company's", "VISTA-16", "clinical", "study", "for", "varespladib.", "<tag3>"], "wordsA": ["We", "expect", "to", "incur", "substantial", "clinical", "development", "costs", "for", "our", "Phase", "3", "clinical", "study", "named", "VISTA-", "16", "for", "varespladib", "and", "for", "our", "Phase", "2b", "clinical", "study", "named", "PEARL-SC", "for", "A-623,", "as", "well", "as", "for", "the", "development", "of", "our", "other", "product", "candidates."], "wordsB": ["On", "March", "9,", "2012,", "an", "independent", "data", "safety", "monitoring", "board", "(DSMB)", "recommended", "stopping", "the", "Company's", "VISTA-16", "clinical", "study", "for", "varespladib."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p4_s5", "idA": "1316175_11_item7_p12_s1", "sentA": "We expect to incur substantial clinical development costs for our Phase 3 clinical study named VISTA- 16 for varespladib and for our Phase 2b clinical study named PEARL-SC for A-623, as well as for the development of our other product candidates.", "sentB": "We have also closed enrollment in our IMPACTS-2 clinical study for varespladib sodium.", "type": 1, "words": ["<tag1>", "We", "expect", "to", "incur", "substantial", "clinical", "development", "costs", "for", "our", "Phase", "3", "clinical", "study", "named", "VISTA-", "16", "for", "varespladib", "and", "for", "our", "Phase", "2b", "clinical", "study", "named", "PEARL-SC", "for", "A-623,", "as", "well", "as", "for", "the", "development", "of", "our", "other", "product", "candidates.", "<tag2>", "We", "have", "also", "closed", "enrollment", "in", "our", "IMPACTS-2", "clinical", "study", "for", "varespladib", "sodium.", "<tag3>"], "wordsA": ["We", "expect", "to", "incur", "substantial", "clinical", "development", "costs", "for", "our", "Phase", "3", "clinical", "study", "named", "VISTA-", "16", "for", "varespladib", "and", "for", "our", "Phase", "2b", "clinical", "study", "named", "PEARL-SC", "for", "A-623,", "as", "well", "as", "for", "the", "development", "of", "our", "other", "product", "candidates."], "wordsB": ["We", "have", "also", "closed", "enrollment", "in", "our", "IMPACTS-2", "clinical", "study", "for", "varespladib", "sodium."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p68_s4", "idA": "1316175_11_item7_p16_s0", "sentA": "Includes Qualifying Therapeutic Discovery Project Credit under Section 48D of approximately $244,000.", "sentB": "Thereafter, the loan will be repaid in 30 equal monthly installments of approximately $1.0 million, at the initial interest rate.", "type": 1, "words": ["<tag1>", "Includes", "Qualifying", "Therapeutic", "Discovery", "Project", "Credit", "under", "Section", "48D", "of", "approximately", "$244,000.", "<tag2>", "Thereafter,", "the", "loan", "will", "be", "repaid", "in", "30", "equal", "monthly", "installments", "of", "approximately", "$1.0", "million,", "at", "the", "initial", "interest", "rate.", "<tag3>"], "wordsA": ["Includes", "Qualifying", "Therapeutic", "Discovery", "Project", "Credit", "under", "Section", "48D", "of", "approximately", "$244,000."], "wordsB": ["Thereafter,", "the", "loan", "will", "be", "repaid", "in", "30", "equal", "monthly", "installments", "of", "approximately", "$1.0", "million,", "at", "the", "initial", "interest", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p68_s3", "idA": "1316175_11_item7_p21_s1", "sentA": "We began enrollment of patients in the VISTA-16 study of varespladib for the treatment of patients experiencing acute coronary syndrome in June 2010.", "sentB": "The Company will make interest only payments for the initial 15 months.", "type": 1, "words": ["<tag1>", "We", "began", "enrollment", "of", "patients", "in", "the", "VISTA-16", "study", "of", "varespladib", "for", "the", "treatment", "of", "patients", "experiencing", "acute", "coronary", "syndrome", "in", "June", "2010.", "<tag2>", "The", "Company", "will", "make", "interest", "only", "payments", "for", "the", "initial", "15", "months.", "<tag3>"], "wordsA": ["We", "began", "enrollment", "of", "patients", "in", "the", "VISTA-16", "study", "of", "varespladib", "for", "the", "treatment", "of", "patients", "experiencing", "acute", "coronary", "syndrome", "in", "June", "2010."], "wordsB": ["The", "Company", "will", "make", "interest", "only", "payments", "for", "the", "initial", "15", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p70_s0", "idA": "1316175_11_item7_p24_s0", "sentA": "Our expenses related to clinical studies are based on estimates of the services received and efforts expended pursuant to contracts with multiple research institutions and clinical research organizations that conduct and manage clinical studies on our behalf.", "sentB": "(1) Interest payments reflected are estimated based on an interest rate of 10.55% throughout the term of the note, plus an additional end of term charge of $938.", "type": 1, "words": ["<tag1>", "Our", "expenses", "related", "to", "clinical", "studies", "are", "based", "on", "estimates", "of", "the", "services", "received", "and", "efforts", "expended", "pursuant", "to", "contracts", "with", "multiple", "research", "institutions", "and", "clinical", "research", "organizations", "that", "conduct", "and", "manage", "clinical", "studies", "on", "our", "behalf.", "<tag2>", "(1)", "Interest", "payments", "reflected", "are", "estimated", "based", "on", "an", "interest", "rate", "of", "10.55%", "throughout", "the", "term", "of", "the", "note,", "plus", "an", "additional", "end", "of", "term", "charge", "of", "$938.", "<tag3>"], "wordsA": ["Our", "expenses", "related", "to", "clinical", "studies", "are", "based", "on", "estimates", "of", "the", "services", "received", "and", "efforts", "expended", "pursuant", "to", "contracts", "with", "multiple", "research", "institutions", "and", "clinical", "research", "organizations", "that", "conduct", "and", "manage", "clinical", "studies", "on", "our", "behalf."], "wordsB": ["(1)", "Interest", "payments", "reflected", "are", "estimated", "based", "on", "an", "interest", "rate", "of", "10.55%", "throughout", "the", "term", "of", "the", "note,", "plus", "an", "additional", "end", "of", "term", "charge", "of", "$938."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p7_s0", "idA": "1316175_11_item7_p30_s0", "sentA": "While our significant accounting policies are more fully described in the accompanying notes to the financial statements, we believe that the following accounting policies are the most critical to aid you in fully understanding and evaluating our reported financial results and affect the more significant judgments and estimates that we use in the preparation of our financial statements.", "sentB": "In January 2012, Anthera Pharmaceuticals, Limited, a wholly-owned subsidiary, was incorporated in Ireland.", "type": 1, "words": ["<tag1>", "While", "our", "significant", "accounting", "policies", "are", "more", "fully", "described", "in", "the", "accompanying", "notes", "to", "the", "financial", "statements,", "we", "believe", "that", "the", "following", "accounting", "policies", "are", "the", "most", "critical", "to", "aid", "you", "in", "fully", "understanding", "and", "evaluating", "our", "reported", "financial", "results", "and", "affect", "the", "more", "significant", "judgments", "and", "estimates", "that", "we", "use", "in", "the", "preparation", "of", "our", "financial", "statements.", "<tag2>", "In", "January", "2012,", "Anthera", "Pharmaceuticals,", "Limited,", "a", "wholly-owned", "subsidiary,", "was", "incorporated", "in", "Ireland.", "<tag3>"], "wordsA": ["While", "our", "significant", "accounting", "policies", "are", "more", "fully", "described", "in", "the", "accompanying", "notes", "to", "the", "financial", "statements,", "we", "believe", "that", "the", "following", "accounting", "policies", "are", "the", "most", "critical", "to", "aid", "you", "in", "fully", "understanding", "and", "evaluating", "our", "reported", "financial", "results", "and", "affect", "the", "more", "significant", "judgments", "and", "estimates", "that", "we", "use", "in", "the", "preparation", "of", "our", "financial", "statements."], "wordsB": ["In", "January", "2012,", "Anthera", "Pharmaceuticals,", "Limited,", "a", "wholly-owned", "subsidiary,", "was", "incorporated", "in", "Ireland."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p4_s3", "idA": "1316175_11_item7_p40_s3", "sentA": "Unobservable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.", "sentB": "We believe that the DSMB's decision was based on the belief that the risk profile of the drug would not outweigh any benefit.", "type": 1, "words": ["<tag1>", "Unobservable", "inputs", "are", "inputs", "that", "reflect", "the", "assumptions", "market", "participants", "would", "use", "in", "pricing", "the", "asset", "or", "liability", "based", "on", "the", "best", "information", "available", "in", "the", "circumstances.", "<tag2>", "We", "believe", "that", "the", "DSMB's", "decision", "was", "based", "on", "the", "belief", "that", "the", "risk", "profile", "of", "the", "drug", "would", "not", "outweigh", "any", "benefit.", "<tag3>"], "wordsA": ["Unobservable", "inputs", "are", "inputs", "that", "reflect", "the", "assumptions", "market", "participants", "would", "use", "in", "pricing", "the", "asset", "or", "liability", "based", "on", "the", "best", "information", "available", "in", "the", "circumstances."], "wordsB": ["We", "believe", "that", "the", "DSMB's", "decision", "was", "based", "on", "the", "belief", "that", "the", "risk", "profile", "of", "the", "drug", "would", "not", "outweigh", "any", "benefit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p4_s1", "idA": "1316175_11_item7_p47_s4", "sentA": "Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.", "sentB": "After review of the totality of evidence, including the emerging unblinded data from VISTA-16, the DSMB was unanimous in its view that there was cogent evidence to recommend early termination of the trial.", "type": 1, "words": ["<tag1>", "Our", "assessment", "of", "the", "significance", "of", "a", "particular", "input", "to", "the", "fair", "value", "measurement", "in", "its", "entirety", "requires", "judgment", "and", "considers", "factors", "specific", "to", "the", "investment.", "<tag2>", "After", "review", "of", "the", "totality", "of", "evidence,", "including", "the", "emerging", "unblinded", "data", "from", "VISTA-16,", "the", "DSMB", "was", "unanimous", "in", "its", "view", "that", "there", "was", "cogent", "evidence", "to", "recommend", "early", "termination", "of", "the", "trial.", "<tag3>"], "wordsA": ["Our", "assessment", "of", "the", "significance", "of", "a", "particular", "input", "to", "the", "fair", "value", "measurement", "in", "its", "entirety", "requires", "judgment", "and", "considers", "factors", "specific", "to", "the", "investment."], "wordsB": ["After", "review", "of", "the", "totality", "of", "evidence,", "including", "the", "emerging", "unblinded", "data", "from", "VISTA-16,", "the", "DSMB", "was", "unanimous", "in", "its", "view", "that", "there", "was", "cogent", "evidence", "to", "recommend", "early", "termination", "of", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p4_s2", "idA": "1316175_11_item7_p47_s4", "sentA": "Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.", "sentB": "According to the DSMB, the chief reason is the inability of VISTA-16 to detect a statistically significant benefit of the drug on the prespecified primary and secondary endpoints even if the trial continues to its scheduled termination.", "type": 1, "words": ["<tag1>", "Our", "assessment", "of", "the", "significance", "of", "a", "particular", "input", "to", "the", "fair", "value", "measurement", "in", "its", "entirety", "requires", "judgment", "and", "considers", "factors", "specific", "to", "the", "investment.", "<tag2>", "According", "to", "the", "DSMB,", "the", "chief", "reason", "is", "the", "inability", "of", "VISTA-16", "to", "detect", "a", "statistically", "significant", "benefit", "of", "the", "drug", "on", "the", "prespecified", "primary", "and", "secondary", "endpoints", "even", "if", "the", "trial", "continues", "to", "its", "scheduled", "termination.", "<tag3>"], "wordsA": ["Our", "assessment", "of", "the", "significance", "of", "a", "particular", "input", "to", "the", "fair", "value", "measurement", "in", "its", "entirety", "requires", "judgment", "and", "considers", "factors", "specific", "to", "the", "investment."], "wordsB": ["According", "to", "the", "DSMB,", "the", "chief", "reason", "is", "the", "inability", "of", "VISTA-16", "to", "detect", "a", "statistically", "significant", "benefit", "of", "the", "drug", "on", "the", "prespecified", "primary", "and", "secondary", "endpoints", "even", "if", "the", "trial", "continues", "to", "its", "scheduled", "termination."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p68_s0", "idA": "1316175_11_item7_p52_s2", "sentA": "Specifically, the Company includes unrealized gains (losses) on available for sale securities in other comprehensive income (loss).", "sentB": "On March 25, 2011, the Company entered into a Loan and Security Agreement (\"Loan Agreement\") with Hercules.", "type": 1, "words": ["<tag1>", "Specifically,", "the", "Company", "includes", "unrealized", "gains", "(losses)", "on", "available", "for", "sale", "securities", "in", "other", "comprehensive", "income", "(loss).", "<tag2>", "On", "March", "25,", "2011,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(\"Loan", "Agreement\")", "with", "Hercules.", "<tag3>"], "wordsA": ["Specifically,", "the", "Company", "includes", "unrealized", "gains", "(losses)", "on", "available", "for", "sale", "securities", "in", "other", "comprehensive", "income", "(loss)."], "wordsB": ["On", "March", "25,", "2011,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(\"Loan", "Agreement\")", "with", "Hercules."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p68_s5", "idA": "1316175_11_item7_p83_s2", "sentA": "We are also obligated to pay royalties on future net sales of products that are developed and approved as defined by this collaboration.", "sentB": "The Company will also be obligated to pay an end of the term charge of $0.9 million, which is being expensed over the term of the Loan Agreement using the effective interest rate.", "type": 1, "words": ["<tag1>", "We", "are", "also", "obligated", "to", "pay", "royalties", "on", "future", "net", "sales", "of", "products", "that", "are", "developed", "and", "approved", "as", "defined", "by", "this", "collaboration.", "<tag2>", "The", "Company", "will", "also", "be", "obligated", "to", "pay", "an", "end", "of", "the", "term", "charge", "of", "$0.9", "million,", "which", "is", "being", "expensed", "over", "the", "term", "of", "the", "Loan", "Agreement", "using", "the", "effective", "interest", "rate.", "<tag3>"], "wordsA": ["We", "are", "also", "obligated", "to", "pay", "royalties", "on", "future", "net", "sales", "of", "products", "that", "are", "developed", "and", "approved", "as", "defined", "by", "this", "collaboration."], "wordsB": ["The", "Company", "will", "also", "be", "obligated", "to", "pay", "an", "end", "of", "the", "term", "charge", "of", "$0.9", "million,", "which", "is", "being", "expensed", "over", "the", "term", "of", "the", "Loan", "Agreement", "using", "the", "effective", "interest", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p4_s4", "idA": "1316175_11_item7_p88_s0", "sentA": "To date, we have not generated any revenue.", "sentB": "As a result, we have closed enrollment in the study and informed all investigators to remove patients from therapy immediately.", "type": 1, "words": ["<tag1>", "To", "date,", "we", "have", "not", "generated", "any", "revenue.", "<tag2>", "As", "a", "result,", "we", "have", "closed", "enrollment", "in", "the", "study", "and", "informed", "all", "investigators", "to", "remove", "patients", "from", "therapy", "immediately.", "<tag3>"], "wordsA": ["To", "date,", "we", "have", "not", "generated", "any", "revenue."], "wordsB": ["As", "a", "result,", "we", "have", "closed", "enrollment", "in", "the", "study", "and", "informed", "all", "investigators", "to", "remove", "patients", "from", "therapy", "immediately."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p41_s0", "idA": "1316175_11_item7_p88_s2", "sentA": "We expect our continuing operating losses to result in increases in cash used in operations over the next several years.", "sentB": "approximately $13.9 million over the prior period.", "type": 1, "words": ["<tag1>", "We", "expect", "our", "continuing", "operating", "losses", "to", "result", "in", "increases", "in", "cash", "used", "in", "operations", "over", "the", "next", "several", "years.", "<tag2>", "approximately", "$13.9", "million", "over", "the", "prior", "period.", "<tag3>"], "wordsA": ["We", "expect", "our", "continuing", "operating", "losses", "to", "result", "in", "increases", "in", "cash", "used", "in", "operations", "over", "the", "next", "several", "years."], "wordsB": ["approximately", "$13.9", "million", "over", "the", "prior", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p68_s2", "idA": "1316175_11_item7_p8_s2", "sentA": "We intend to seek to generate revenue from a combination of product sales, up-front fees and milestone payments in connection with collaborative or strategic relationships and royalties resulting from the licensing of the commercial rights to our intellectual property.", "sentB": "The loan is secured by the Company's assets, excluding intellectual property.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "seek", "to", "generate", "revenue", "from", "a", "combination", "of", "product", "sales,", "up-front", "fees", "and", "milestone", "payments", "in", "connection", "with", "collaborative", "or", "strategic", "relationships", "and", "royalties", "resulting", "from", "the", "licensing", "of", "the", "commercial", "rights", "to", "our", "intellectual", "property.", "<tag2>", "The", "loan", "is", "secured", "by", "the", "Company's", "assets,", "excluding", "intellectual", "property.", "<tag3>"], "wordsA": ["We", "intend", "to", "seek", "to", "generate", "revenue", "from", "a", "combination", "of", "product", "sales,", "up-front", "fees", "and", "milestone", "payments", "in", "connection", "with", "collaborative", "or", "strategic", "relationships", "and", "royalties", "resulting", "from", "the", "licensing", "of", "the", "commercial", "rights", "to", "our", "intellectual", "property."], "wordsB": ["The", "loan", "is", "secured", "by", "the", "Company's", "assets,", "excluding", "intellectual", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_12_item7_p68_s1", "idA": "1316175_11_item7_p90_s1", "sentA": "In addition, the terms of any financing may adversely affect the holdings or the rights of our stockholders.", "sentB": "Under the terms of the Loan Agreement, the Company borrowed $25.0 million at an interest rate of the higher of (i) 10.55% or (ii) 7.30% plus the prime rate as reported in the Wall Street Journal, and issued to Hercules a secured term promissory note evidencing the loan.", "type": 1, "words": ["<tag1>", "In", "addition,", "the", "terms", "of", "any", "financing", "may", "adversely", "affect", "the", "holdings", "or", "the", "rights", "of", "our", "stockholders.", "<tag2>", "Under", "the", "terms", "of", "the", "Loan", "Agreement,", "the", "Company", "borrowed", "$25.0", "million", "at", "an", "interest", "rate", "of", "the", "higher", "of", "(i)", "10.55%", "or", "(ii)", "7.30%", "plus", "the", "prime", "rate", "as", "reported", "in", "the", "Wall", "Street", "Journal,", "and", "issued", "to", "Hercules", "a", "secured", "term", "promissory", "note", "evidencing", "the", "loan.", "<tag3>"], "wordsA": ["In", "addition,", "the", "terms", "of", "any", "financing", "may", "adversely", "affect", "the", "holdings", "or", "the", "rights", "of", "our", "stockholders."], "wordsB": ["Under", "the", "terms", "of", "the", "Loan", "Agreement,", "the", "Company", "borrowed", "$25.0", "million", "at", "an", "interest", "rate", "of", "the", "higher", "of", "(i)", "10.55%", "or", "(ii)", "7.30%", "plus", "the", "prime", "rate", "as", "reported", "in", "the", "Wall", "Street", "Journal,", "and", "issued", "to", "Hercules", "a", "secured", "term", "promissory", "note", "evidencing", "the", "loan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p17_s4", "idA": "1316175_12_item7_p17_s0", "sentA": "(1) Includes milestone payments of $3.5 million pursuant to amendments to the license agreements with each of Eli Lilly and Shionogi Co. Ltd., which were paid in the form of shares of common stock.", "sentB": "Therefore, we provided notice of termination to the collaborators in August 2012 to terminate the license agreement.", "type": 1, "words": ["<tag1>", "(1)", "Includes", "milestone", "payments", "of", "$3.5", "million", "pursuant", "to", "amendments", "to", "the", "license", "agreements", "with", "each", "of", "Eli", "Lilly", "and", "Shionogi", "Co.", "Ltd.,", "which", "were", "paid", "in", "the", "form", "of", "shares", "of", "common", "stock.", "<tag2>", "Therefore,", "we", "provided", "notice", "of", "termination", "to", "the", "collaborators", "in", "August", "2012", "to", "terminate", "the", "license", "agreement.", "<tag3>"], "wordsA": ["(1)", "Includes", "milestone", "payments", "of", "$3.5", "million", "pursuant", "to", "amendments", "to", "the", "license", "agreements", "with", "each", "of", "Eli", "Lilly", "and", "Shionogi", "Co.", "Ltd.,", "which", "were", "paid", "in", "the", "form", "of", "shares", "of", "common", "stock."], "wordsB": ["Therefore,", "we", "provided", "notice", "of", "termination", "to", "the", "collaborators", "in", "August", "2012", "to", "terminate", "the", "license", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p17_s5", "idA": "1316175_12_item7_p17_s2", "sentA": "(3) Includes a one-time license initiation fee of $6.0 million pursuant to a license agreement with Amgen.", "sentB": "The license agreement was effectively terminated in November 2012.", "type": 1, "words": ["<tag1>", "(3)", "Includes", "a", "one-time", "license", "initiation", "fee", "of", "$6.0", "million", "pursuant", "to", "a", "license", "agreement", "with", "Amgen.", "<tag2>", "The", "license", "agreement", "was", "effectively", "terminated", "in", "November", "2012.", "<tag3>"], "wordsA": ["(3)", "Includes", "a", "one-time", "license", "initiation", "fee", "of", "$6.0", "million", "pursuant", "to", "a", "license", "agreement", "with", "Amgen."], "wordsB": ["The", "license", "agreement", "was", "effectively", "terminated", "in", "November", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p11_s5", "idA": "1316175_12_item7_p18_s1", "sentA": "We completed enrollment in the PEARL-SC study of blisibimod in October 2011.", "sentB": "We plan to conduct an interim analysis after the eight-week induction phase to determine effects of blisibimod on proteinuria.", "type": 1, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "PEARL-SC", "study", "of", "blisibimod", "in", "October", "2011.", "<tag2>", "We", "plan", "to", "conduct", "an", "interim", "analysis", "after", "the", "eight-week", "induction", "phase", "to", "determine", "effects", "of", "blisibimod", "on", "proteinuria.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "PEARL-SC", "study", "of", "blisibimod", "in", "October", "2011."], "wordsB": ["We", "plan", "to", "conduct", "an", "interim", "analysis", "after", "the", "eight-week", "induction", "phase", "to", "determine", "effects", "of", "blisibimod", "on", "proteinuria."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p9_s2", "idA": "1316175_12_item7_p18_s1", "sentA": "We completed enrollment in the PEARL-SC study of blisibimod in October 2011.", "sentB": "The Phase 3 studies (CHABLIS-SC1 and CHABLIS-SC2) are planned to be multicenter, placebo-controlled, randomized, double-blind studies designed to evaluate the efficacy, safety, tolerability and immunogenicity of blisibimod in patients with clinically active SLE (SELENA-SLEDAI 10) who require corticosteroid therapy in addition to standard-of-care for treatment of their disease.", "type": 1, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "PEARL-SC", "study", "of", "blisibimod", "in", "October", "2011.", "<tag2>", "The", "Phase", "3", "studies", "(CHABLIS-SC1", "and", "CHABLIS-SC2)", "are", "planned", "to", "be", "multicenter,", "placebo-controlled,", "randomized,", "double-blind", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "tolerability", "and", "immunogenicity", "of", "blisibimod", "in", "patients", "with", "clinically", "active", "SLE", "(SELENA-SLEDAI", "10)", "who", "require", "corticosteroid", "therapy", "in", "addition", "to", "standard-of-care", "for", "treatment", "of", "their", "disease.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "PEARL-SC", "study", "of", "blisibimod", "in", "October", "2011."], "wordsB": ["The", "Phase", "3", "studies", "(CHABLIS-SC1", "and", "CHABLIS-SC2)", "are", "planned", "to", "be", "multicenter,", "placebo-controlled,", "randomized,", "double-blind", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "tolerability", "and", "immunogenicity", "of", "blisibimod", "in", "patients", "with", "clinically", "active", "SLE", "(SELENA-SLEDAI", "10)", "who", "require", "corticosteroid", "therapy", "in", "addition", "to", "standard-of-care", "for", "treatment", "of", "their", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p9_s3", "idA": "1316175_12_item7_p18_s1", "sentA": "We completed enrollment in the PEARL-SC study of blisibimod in October 2011.", "sentB": "Each study will randomize approximately 400 patients to receive either 200mg of blisibimod or placebo for 52 weeks.", "type": 1, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "PEARL-SC", "study", "of", "blisibimod", "in", "October", "2011.", "<tag2>", "Each", "study", "will", "randomize", "approximately", "400", "patients", "to", "receive", "either", "200mg", "of", "blisibimod", "or", "placebo", "for", "52", "weeks.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "PEARL-SC", "study", "of", "blisibimod", "in", "October", "2011."], "wordsB": ["Each", "study", "will", "randomize", "approximately", "400", "patients", "to", "receive", "either", "200mg", "of", "blisibimod", "or", "placebo", "for", "52", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p9_s4", "idA": "1316175_12_item7_p19_s0", "sentA": "We expect that a large percentage of our research and development expenses in the future will be incurred in support of our current and future clinical development programs.", "sentB": "As agreed with the FDA, the primary endpoint of the Phase 3 studies will be clinical improvement in the SRI-8 response at 52 weeks.", "type": 1, "words": ["<tag1>", "We", "expect", "that", "a", "large", "percentage", "of", "our", "research", "and", "development", "expenses", "in", "the", "future", "will", "be", "incurred", "in", "support", "of", "our", "current", "and", "future", "clinical", "development", "programs.", "<tag2>", "As", "agreed", "with", "the", "FDA,", "the", "primary", "endpoint", "of", "the", "Phase", "3", "studies", "will", "be", "clinical", "improvement", "in", "the", "SRI-8", "response", "at", "52", "weeks.", "<tag3>"], "wordsA": ["We", "expect", "that", "a", "large", "percentage", "of", "our", "research", "and", "development", "expenses", "in", "the", "future", "will", "be", "incurred", "in", "support", "of", "our", "current", "and", "future", "clinical", "development", "programs."], "wordsB": ["As", "agreed", "with", "the", "FDA,", "the", "primary", "endpoint", "of", "the", "Phase", "3", "studies", "will", "be", "clinical", "improvement", "in", "the", "SRI-8", "response", "at", "52", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p17_s1", "idA": "1316175_12_item7_p20_s2", "sentA": "The cost of clinical studies may vary significantly over the life of a program as a result of differences arising during clinical development, including:", "sentB": "We modified work orders with key vendors to ensure wind-down activities were efficient, while still maintaining patient safety as a top priority.", "type": 1, "words": ["<tag1>", "The", "cost", "of", "clinical", "studies", "may", "vary", "significantly", "over", "the", "life", "of", "a", "program", "as", "a", "result", "of", "differences", "arising", "during", "clinical", "development,", "including:", "<tag2>", "We", "modified", "work", "orders", "with", "key", "vendors", "to", "ensure", "wind-down", "activities", "were", "efficient,", "while", "still", "maintaining", "patient", "safety", "as", "a", "top", "priority.", "<tag3>"], "wordsA": ["The", "cost", "of", "clinical", "studies", "may", "vary", "significantly", "over", "the", "life", "of", "a", "program", "as", "a", "result", "of", "differences", "arising", "during", "clinical", "development,", "including:"], "wordsB": ["We", "modified", "work", "orders", "with", "key", "vendors", "to", "ensure", "wind-down", "activities", "were", "efficient,", "while", "still", "maintaining", "patient", "safety", "as", "a", "top", "priority."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p11_s2", "idA": "1316175_12_item7_p24_s1", "sentA": "Payments under the contracts depend on factors such as the successful enrollment of patients or the completion of clinical study milestones.", "sentB": "The BRIGHT-SC study will enroll approximately 48 patients with biopsy-proven IgAN who have proteinuria greater than one gram per 24 hours and are receiving standard of care.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones.", "<tag2>", "The", "BRIGHT-SC", "study", "will", "enroll", "approximately", "48", "patients", "with", "biopsy-proven", "IgAN", "who", "have", "proteinuria", "greater", "than", "one", "gram", "per", "24", "hours", "and", "are", "receiving", "standard", "of", "care.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones."], "wordsB": ["The", "BRIGHT-SC", "study", "will", "enroll", "approximately", "48", "patients", "with", "biopsy-proven", "IgAN", "who", "have", "proteinuria", "greater", "than", "one", "gram", "per", "24", "hours", "and", "are", "receiving", "standard", "of", "care."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p55_s3", "idA": "1316175_12_item7_p24_s1", "sentA": "Payments under the contracts depend on factors such as the successful enrollment of patients or the completion of clinical study milestones.", "sentB": "This facility is no longer available for use.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones.", "<tag2>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones."], "wordsB": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p6_s0", "idA": "1316175_12_item7_p24_s1", "sentA": "Payments under the contracts depend on factors such as the successful enrollment of patients or the completion of clinical study milestones.", "sentB": "The BAFF-R receptor is expressed primarily on peripheral B-cells.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones.", "<tag2>", "The", "BAFF-R", "receptor", "is", "expressed", "primarily", "on", "peripheral", "B-cells.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones."], "wordsB": ["The", "BAFF-R", "receptor", "is", "expressed", "primarily", "on", "peripheral", "B-cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p11_s3", "idA": "1316175_12_item7_p26_s0", "sentA": "As a result of the uncertainties discussed above, we are unable to determine the duration and completion costs of our development projects or when and to what extent we will receive cash inflows from the commercialization and sale of an approved product candidate, if ever.", "sentB": "Patients will receive high dose blisibimod or placebo for 8 weeks, the induction phase, followed by 24 weeks, the maintenance phase, of 200mg weekly blisibimod or placebo.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "the", "uncertainties", "discussed", "above,", "we", "are", "unable", "to", "determine", "the", "duration", "and", "completion", "costs", "of", "our", "development", "projects", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "an", "approved", "product", "candidate,", "if", "ever.", "<tag2>", "Patients", "will", "receive", "high", "dose", "blisibimod", "or", "placebo", "for", "8", "weeks,", "the", "induction", "phase,", "followed", "by", "24", "weeks,", "the", "maintenance", "phase,", "of", "200mg", "weekly", "blisibimod", "or", "placebo.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "uncertainties", "discussed", "above,", "we", "are", "unable", "to", "determine", "the", "duration", "and", "completion", "costs", "of", "our", "development", "projects", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "the", "commercialization", "and", "sale", "of", "an", "approved", "product", "candidate,", "if", "ever."], "wordsB": ["Patients", "will", "receive", "high", "dose", "blisibimod", "or", "placebo", "for", "8", "weeks,", "the", "induction", "phase,", "followed", "by", "24", "weeks,", "the", "maintenance", "phase,", "of", "200mg", "weekly", "blisibimod", "or", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p11_s1", "idA": "1316175_12_item7_p2_s1", "sentA": "We currently have one Phase 2 clinical program, blisibimod.", "sentB": "Following the encouraging results from the Phase 2b PEARL-SC study, we plan to initiate patient enrollment in a Phase 2 proof-of-concept study for the treatment of IgA nephropathy (BRIGHT-SC) in 2013, our first orphan indication for the treatment renal disease and will serve as our initial catalyst for a Phase 3 path in renal diseases with blisibimod.", "type": 1, "words": ["<tag1>", "We", "currently", "have", "one", "Phase", "2", "clinical", "program,", "blisibimod.", "<tag2>", "Following", "the", "encouraging", "results", "from", "the", "Phase", "2b", "PEARL-SC", "study,", "we", "plan", "to", "initiate", "patient", "enrollment", "in", "a", "Phase", "2", "proof-of-concept", "study", "for", "the", "treatment", "of", "IgA", "nephropathy", "(BRIGHT-SC)", "in", "2013,", "our", "first", "orphan", "indication", "for", "the", "treatment", "renal", "disease", "and", "will", "serve", "as", "our", "initial", "catalyst", "for", "a", "Phase", "3", "path", "in", "renal", "diseases", "with", "blisibimod.", "<tag3>"], "wordsA": ["We", "currently", "have", "one", "Phase", "2", "clinical", "program,", "blisibimod."], "wordsB": ["Following", "the", "encouraging", "results", "from", "the", "Phase", "2b", "PEARL-SC", "study,", "we", "plan", "to", "initiate", "patient", "enrollment", "in", "a", "Phase", "2", "proof-of-concept", "study", "for", "the", "treatment", "of", "IgA", "nephropathy", "(BRIGHT-SC)", "in", "2013,", "our", "first", "orphan", "indication", "for", "the", "treatment", "renal", "disease", "and", "will", "serve", "as", "our", "initial", "catalyst", "for", "a", "Phase", "3", "path", "in", "renal", "diseases", "with", "blisibimod."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p8_s0", "idA": "1316175_12_item7_p2_s2", "sentA": "Two of our product candidates, varespladib and varespladib sodium, are designed to inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2.", "sentB": "A peptibody is a novel fusion protein that is distinct from an antibody with several potential advantages including ease of manufacture and relatively small molecular weight.", "type": 1, "words": ["<tag1>", "Two", "of", "our", "product", "candidates,", "varespladib", "and", "varespladib", "sodium,", "are", "designed", "to", "inhibit", "a", "novel", "enzyme", "target", "known", "as", "secretory", "phospholipase", "A2,", "or", "sPLA2.", "<tag2>", "A", "peptibody", "is", "a", "novel", "fusion", "protein", "that", "is", "distinct", "from", "an", "antibody", "with", "several", "potential", "advantages", "including", "ease", "of", "manufacture", "and", "relatively", "small", "molecular", "weight.", "<tag3>"], "wordsA": ["Two", "of", "our", "product", "candidates,", "varespladib", "and", "varespladib", "sodium,", "are", "designed", "to", "inhibit", "a", "novel", "enzyme", "target", "known", "as", "secretory", "phospholipase", "A2,", "or", "sPLA2."], "wordsB": ["A", "peptibody", "is", "a", "novel", "fusion", "protein", "that", "is", "distinct", "from", "an", "antibody", "with", "several", "potential", "advantages", "including", "ease", "of", "manufacture", "and", "relatively", "small", "molecular", "weight."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p53_s0", "idA": "1316175_12_item7_p32_s0", "sentA": "periodically confirm the accuracy of our estimates with the service providers and make adjustments if necessary.", "sentB": "We filed a universal shelf registration statement with the SEC on Form S-3 (File No. 333-179043) on January 17, 2012, which was declared effective on January 24, 2012, for the proposed offering from time to time of up to $100.0 million of our securities, including common stock, preferred stock, debt securities and/or warrants.", "type": 1, "words": ["<tag1>", "periodically", "confirm", "the", "accuracy", "of", "our", "estimates", "with", "the", "service", "providers", "and", "make", "adjustments", "if", "necessary.", "<tag2>", "We", "filed", "a", "universal", "shelf", "registration", "statement", "with", "the", "SEC", "on", "Form", "S-3", "(File", "No.", "333-179043)", "on", "January", "17,", "2012,", "which", "was", "declared", "effective", "on", "January", "24,", "2012,", "for", "the", "proposed", "offering", "from", "time", "to", "time", "of", "up", "to", "$100.0", "million", "of", "our", "securities,", "including", "common", "stock,", "preferred", "stock,", "debt", "securities", "and/or", "warrants.", "<tag3>"], "wordsA": ["periodically", "confirm", "the", "accuracy", "of", "our", "estimates", "with", "the", "service", "providers", "and", "make", "adjustments", "if", "necessary."], "wordsB": ["We", "filed", "a", "universal", "shelf", "registration", "statement", "with", "the", "SEC", "on", "Form", "S-3", "(File", "No.", "333-179043)", "on", "January", "17,", "2012,", "which", "was", "declared", "effective", "on", "January", "24,", "2012,", "for", "the", "proposed", "offering", "from", "time", "to", "time", "of", "up", "to", "$100.0", "million", "of", "our", "securities,", "including", "common", "stock,", "preferred", "stock,", "debt", "securities", "and/or", "warrants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p11_s4", "idA": "1316175_12_item7_p36_s2", "sentA": "Additionally, we are required to include an estimate of the number of awards that will be forfeited in calculating compensation costs, which are recognized over the requisite service period of the awards on a straight-line basis.", "sentB": "The primary endpoint of the BRIGHT-SC study will be improvements in proteinuria versus placebo after 32 weeks.", "type": 1, "words": ["<tag1>", "Additionally,", "we", "are", "required", "to", "include", "an", "estimate", "of", "the", "number", "of", "awards", "that", "will", "be", "forfeited", "in", "calculating", "compensation", "costs,", "which", "are", "recognized", "over", "the", "requisite", "service", "period", "of", "the", "awards", "on", "a", "straight-line", "basis.", "<tag2>", "The", "primary", "endpoint", "of", "the", "BRIGHT-SC", "study", "will", "be", "improvements", "in", "proteinuria", "versus", "placebo", "after", "32", "weeks.", "<tag3>"], "wordsA": ["Additionally,", "we", "are", "required", "to", "include", "an", "estimate", "of", "the", "number", "of", "awards", "that", "will", "be", "forfeited", "in", "calculating", "compensation", "costs,", "which", "are", "recognized", "over", "the", "requisite", "service", "period", "of", "the", "awards", "on", "a", "straight-line", "basis."], "wordsB": ["The", "primary", "endpoint", "of", "the", "BRIGHT-SC", "study", "will", "be", "improvements", "in", "proteinuria", "versus", "placebo", "after", "32", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p15_s1", "idA": "1316175_12_item7_p4_s1", "sentA": "After review of the totality of evidence, including the emerging unblinded data from VISTA-16, the DSMB was unanimous in its view that there was cogent evidence to recommend early termination of the trial.", "sentB": "In addition to reviewing the primary endpoint data, this review included unblinded review of demographics, baseline characteristics, laboratory results, concomitant medications, treatment emergent adverse events (AEs), and serious adverse events (SAEs).", "type": 1, "words": ["<tag1>", "After", "review", "of", "the", "totality", "of", "evidence,", "including", "the", "emerging", "unblinded", "data", "from", "VISTA-16,", "the", "DSMB", "was", "unanimous", "in", "its", "view", "that", "there", "was", "cogent", "evidence", "to", "recommend", "early", "termination", "of", "the", "trial.", "<tag2>", "In", "addition", "to", "reviewing", "the", "primary", "endpoint", "data,", "this", "review", "included", "unblinded", "review", "of", "demographics,", "baseline", "characteristics,", "laboratory", "results,", "concomitant", "medications,", "treatment", "emergent", "adverse", "events", "(AEs),", "and", "serious", "adverse", "events", "(SAEs).", "<tag3>"], "wordsA": ["After", "review", "of", "the", "totality", "of", "evidence,", "including", "the", "emerging", "unblinded", "data", "from", "VISTA-16,", "the", "DSMB", "was", "unanimous", "in", "its", "view", "that", "there", "was", "cogent", "evidence", "to", "recommend", "early", "termination", "of", "the", "trial."], "wordsB": ["In", "addition", "to", "reviewing", "the", "primary", "endpoint", "data,", "this", "review", "included", "unblinded", "review", "of", "demographics,", "baseline", "characteristics,", "laboratory", "results,", "concomitant", "medications,", "treatment", "emergent", "adverse", "events", "(AEs),", "and", "serious", "adverse", "events", "(SAEs)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p45_s1", "idA": "1316175_12_item7_p4_s1", "sentA": "After review of the totality of evidence, including the emerging unblinded data from VISTA-16, the DSMB was unanimous in its view that there was cogent evidence to recommend early termination of the trial.", "sentB": "Furthermore, we reduced our spending on consulting and professional services in line with the termination of the varespladib program.", "type": 1, "words": ["<tag1>", "After", "review", "of", "the", "totality", "of", "evidence,", "including", "the", "emerging", "unblinded", "data", "from", "VISTA-16,", "the", "DSMB", "was", "unanimous", "in", "its", "view", "that", "there", "was", "cogent", "evidence", "to", "recommend", "early", "termination", "of", "the", "trial.", "<tag2>", "Furthermore,", "we", "reduced", "our", "spending", "on", "consulting", "and", "professional", "services", "in", "line", "with", "the", "termination", "of", "the", "varespladib", "program.", "<tag3>"], "wordsA": ["After", "review", "of", "the", "totality", "of", "evidence,", "including", "the", "emerging", "unblinded", "data", "from", "VISTA-16,", "the", "DSMB", "was", "unanimous", "in", "its", "view", "that", "there", "was", "cogent", "evidence", "to", "recommend", "early", "termination", "of", "the", "trial."], "wordsB": ["Furthermore,", "we", "reduced", "our", "spending", "on", "consulting", "and", "professional", "services", "in", "line", "with", "the", "termination", "of", "the", "varespladib", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p11_s0", "idA": "1316175_12_item7_p4_s2", "sentA": "According to the DSMB, the chief reason is the inability of VISTA-16 to detect a statistically significant benefit of the drug on the prespecified primary and secondary endpoints even if the trial continues to its scheduled termination.", "sentB": "Results from the Phase 2b PEARL-SC study that was completed in 2012 showed a statistically significant treatment reduction in proteinuria in both the pooled blisibimod treatment group and the 200mg weekly blisibimod treatment group.", "type": 1, "words": ["<tag1>", "According", "to", "the", "DSMB,", "the", "chief", "reason", "is", "the", "inability", "of", "VISTA-16", "to", "detect", "a", "statistically", "significant", "benefit", "of", "the", "drug", "on", "the", "prespecified", "primary", "and", "secondary", "endpoints", "even", "if", "the", "trial", "continues", "to", "its", "scheduled", "termination.", "<tag2>", "Results", "from", "the", "Phase", "2b", "PEARL-SC", "study", "that", "was", "completed", "in", "2012", "showed", "a", "statistically", "significant", "treatment", "reduction", "in", "proteinuria", "in", "both", "the", "pooled", "blisibimod", "treatment", "group", "and", "the", "200mg", "weekly", "blisibimod", "treatment", "group.", "<tag3>"], "wordsA": ["According", "to", "the", "DSMB,", "the", "chief", "reason", "is", "the", "inability", "of", "VISTA-16", "to", "detect", "a", "statistically", "significant", "benefit", "of", "the", "drug", "on", "the", "prespecified", "primary", "and", "secondary", "endpoints", "even", "if", "the", "trial", "continues", "to", "its", "scheduled", "termination."], "wordsB": ["Results", "from", "the", "Phase", "2b", "PEARL-SC", "study", "that", "was", "completed", "in", "2012", "showed", "a", "statistically", "significant", "treatment", "reduction", "in", "proteinuria", "in", "both", "the", "pooled", "blisibimod", "treatment", "group", "and", "the", "200mg", "weekly", "blisibimod", "treatment", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p17_s2", "idA": "1316175_12_item7_p4_s5", "sentA": "We have also closed enrollment in our IMPACTS-2 clinical study for varespladib sodium.", "sentB": "We have reallocated our remaining resources to other potential development programs and product portfolio efforts.", "type": 1, "words": ["<tag1>", "We", "have", "also", "closed", "enrollment", "in", "our", "IMPACTS-2", "clinical", "study", "for", "varespladib", "sodium.", "<tag2>", "We", "have", "reallocated", "our", "remaining", "resources", "to", "other", "potential", "development", "programs", "and", "product", "portfolio", "efforts.", "<tag3>"], "wordsA": ["We", "have", "also", "closed", "enrollment", "in", "our", "IMPACTS-2", "clinical", "study", "for", "varespladib", "sodium."], "wordsB": ["We", "have", "reallocated", "our", "remaining", "resources", "to", "other", "potential", "development", "programs", "and", "product", "portfolio", "efforts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p5_s1", "idA": "1316175_12_item7_p53_s2", "sentA": "The decrease in expense is primarily a result of increased income on higher cash and investment balances in 2010 as compared to the prior year.", "sentB": "It is primarily expressed by macrophages, monocytes and dendritic cells and interacts with three different receptors on B-cells including BAFF receptor, or BAFF-R, B-cell maturation, or BCMA, and transmembrane activator and cyclophilin ligand interactor, or TACI.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "expense", "is", "primarily", "a", "result", "of", "increased", "income", "on", "higher", "cash", "and", "investment", "balances", "in", "2010", "as", "compared", "to", "the", "prior", "year.", "<tag2>", "It", "is", "primarily", "expressed", "by", "macrophages,", "monocytes", "and", "dendritic", "cells", "and", "interacts", "with", "three", "different", "receptors", "on", "B-cells", "including", "BAFF", "receptor,", "or", "BAFF-R,", "B-cell", "maturation,", "or", "BCMA,", "and", "transmembrane", "activator", "and", "cyclophilin", "ligand", "interactor,", "or", "TACI.", "<tag3>"], "wordsA": ["The", "decrease", "in", "expense", "is", "primarily", "a", "result", "of", "increased", "income", "on", "higher", "cash", "and", "investment", "balances", "in", "2010", "as", "compared", "to", "the", "prior", "year."], "wordsB": ["It", "is", "primarily", "expressed", "by", "macrophages,", "monocytes", "and", "dendritic", "cells", "and", "interacts", "with", "three", "different", "receptors", "on", "B-cells", "including", "BAFF", "receptor,", "or", "BAFF-R,", "B-cell", "maturation,", "or", "BCMA,", "and", "transmembrane", "activator", "and", "cyclophilin", "ligand", "interactor,", "or", "TACI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p16_s1", "idA": "1316175_12_item7_p56_s0", "sentA": "Cash, cash equivalents and investments consist of the following (in thousands):", "sentB": "At the time of study termination the hazard ratio for the primary endpoint (time to first occurrence of the combined endpoint of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or documented unstable angina with objective evidence of ischemia requiring hospitalization) was 1.244 (p=0.155).", "type": 1, "words": ["<tag1>", "Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "thousands):", "<tag2>", "At", "the", "time", "of", "study", "termination", "the", "hazard", "ratio", "for", "the", "primary", "endpoint", "(time", "to", "first", "occurrence", "of", "the", "combined", "endpoint", "of", "cardiovascular", "death,", "non-fatal", "myocardial", "infarction,", "non-fatal", "stroke,", "or", "documented", "unstable", "angina", "with", "objective", "evidence", "of", "ischemia", "requiring", "hospitalization)", "was", "1.244", "(p=0.155).", "<tag3>"], "wordsA": ["Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "thousands):"], "wordsB": ["At", "the", "time", "of", "study", "termination", "the", "hazard", "ratio", "for", "the", "primary", "endpoint", "(time", "to", "first", "occurrence", "of", "the", "combined", "endpoint", "of", "cardiovascular", "death,", "non-fatal", "myocardial", "infarction,", "non-fatal", "stroke,", "or", "documented", "unstable", "angina", "with", "objective", "evidence", "of", "ischemia", "requiring", "hospitalization)", "was", "1.244", "(p=0.155)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p16_s0", "idA": "1316175_12_item7_p58_s2", "sentA": "The primary drivers for the difference are adjustments for non-cash charges of $4.6 million in clinical trial accruals and changes in other operating assets and liabilities of $14.4 million, which are based upon our estimated clinical trial performance to date.", "sentB": "No obvious clinical or scientific reason has been found for the increased hazard for non-fatal myocardial infarction amongst subjects treated with varespladib despite positive treatment-related changes in LDL-C and CRP.", "type": 1, "words": ["<tag1>", "The", "primary", "drivers", "for", "the", "difference", "are", "adjustments", "for", "non-cash", "charges", "of", "$4.6", "million", "in", "clinical", "trial", "accruals", "and", "changes", "in", "other", "operating", "assets", "and", "liabilities", "of", "$14.4", "million,", "which", "are", "based", "upon", "our", "estimated", "clinical", "trial", "performance", "to", "date.", "<tag2>", "No", "obvious", "clinical", "or", "scientific", "reason", "has", "been", "found", "for", "the", "increased", "hazard", "for", "non-fatal", "myocardial", "infarction", "amongst", "subjects", "treated", "with", "varespladib", "despite", "positive", "treatment-related", "changes", "in", "LDL-C", "and", "CRP.", "<tag3>"], "wordsA": ["The", "primary", "drivers", "for", "the", "difference", "are", "adjustments", "for", "non-cash", "charges", "of", "$4.6", "million", "in", "clinical", "trial", "accruals", "and", "changes", "in", "other", "operating", "assets", "and", "liabilities", "of", "$14.4", "million,", "which", "are", "based", "upon", "our", "estimated", "clinical", "trial", "performance", "to", "date."], "wordsB": ["No", "obvious", "clinical", "or", "scientific", "reason", "has", "been", "found", "for", "the", "increased", "hazard", "for", "non-fatal", "myocardial", "infarction", "amongst", "subjects", "treated", "with", "varespladib", "despite", "positive", "treatment-related", "changes", "in", "LDL-C", "and", "CRP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p57_s0", "idA": "1316175_12_item7_p59_s1", "sentA": "The net loss is higher than cash used in operating activities by $12.6 million.", "sentB": "During the years ended 2012 and 2011, our operating activities used cash of $73.6 million and $73.1 million, respectively, primarily resulting from our net losses and changes in our working capital accounts.", "type": 1, "words": ["<tag1>", "The", "net", "loss", "is", "higher", "than", "cash", "used", "in", "operating", "activities", "by", "$12.6", "million.", "<tag2>", "During", "the", "years", "ended", "2012", "and", "2011,", "our", "operating", "activities", "used", "cash", "of", "$73.6", "million", "and", "$73.1", "million,", "respectively,", "primarily", "resulting", "from", "our", "net", "losses", "and", "changes", "in", "our", "working", "capital", "accounts.", "<tag3>"], "wordsA": ["The", "net", "loss", "is", "higher", "than", "cash", "used", "in", "operating", "activities", "by", "$12.6", "million."], "wordsB": ["During", "the", "years", "ended", "2012", "and", "2011,", "our", "operating", "activities", "used", "cash", "of", "$73.6", "million", "and", "$73.1", "million,", "respectively,", "primarily", "resulting", "from", "our", "net", "losses", "and", "changes", "in", "our", "working", "capital", "accounts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p55_s0", "idA": "1316175_12_item7_p68_s0", "sentA": "On March 25, 2011, the Company entered into a Loan and Security Agreement (\"Loan Agreement\") with Hercules.", "sentB": "On November 8, 2012, we entered into an At Market Issuance Sales Agreement (the Agreement ) with MLV Co.", "type": 1, "words": ["<tag1>", "On", "March", "25,", "2011,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(\"Loan", "Agreement\")", "with", "Hercules.", "<tag2>", "On", "November", "8,", "2012,", "we", "entered", "into", "an", "At", "Market", "Issuance", "Sales", "Agreement", "(the", "Agreement", ")", "with", "MLV", "Co.", "<tag3>"], "wordsA": ["On", "March", "25,", "2011,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(\"Loan", "Agreement\")", "with", "Hercules."], "wordsB": ["On", "November", "8,", "2012,", "we", "entered", "into", "an", "At", "Market", "Issuance", "Sales", "Agreement", "(the", "Agreement", ")", "with", "MLV", "Co."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p55_s1", "idA": "1316175_12_item7_p68_s0", "sentA": "On March 25, 2011, the Company entered into a Loan and Security Agreement (\"Loan Agreement\") with Hercules.", "sentB": "LLC ( MLV ), to create an at-the-market equity program under which the Company from time to time may offer and sell shares of its common stock, par value $0.001 per share, having an aggregate offering price of up to $25,000,000 (the Shares ) through MLV, as agent.", "type": 1, "words": ["<tag1>", "On", "March", "25,", "2011,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(\"Loan", "Agreement\")", "with", "Hercules.", "<tag2>", "LLC", "(", "MLV", "),", "to", "create", "an", "at-the-market", "equity", "program", "under", "which", "the", "Company", "from", "time", "to", "time", "may", "offer", "and", "sell", "shares", "of", "its", "common", "stock,", "par", "value", "$0.001", "per", "share,", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25,000,000", "(the", "Shares", ")", "through", "MLV,", "as", "agent.", "<tag3>"], "wordsA": ["On", "March", "25,", "2011,", "the", "Company", "entered", "into", "a", "Loan", "and", "Security", "Agreement", "(\"Loan", "Agreement\")", "with", "Hercules."], "wordsB": ["LLC", "(", "MLV", "),", "to", "create", "an", "at-the-market", "equity", "program", "under", "which", "the", "Company", "from", "time", "to", "time", "may", "offer", "and", "sell", "shares", "of", "its", "common", "stock,", "par", "value", "$0.001", "per", "share,", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25,000,000", "(the", "Shares", ")", "through", "MLV,", "as", "agent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p15_s0", "idA": "1316175_12_item7_p68_s2", "sentA": "The loan is secured by the Company's assets, excluding intellectual property.", "sentB": "The same data reviewed by the DSMB were subsequently brought in-house and examined by a committee of medical and drug safety professionals.", "type": 1, "words": ["<tag1>", "The", "loan", "is", "secured", "by", "the", "Company's", "assets,", "excluding", "intellectual", "property.", "<tag2>", "The", "same", "data", "reviewed", "by", "the", "DSMB", "were", "subsequently", "brought", "in-house", "and", "examined", "by", "a", "committee", "of", "medical", "and", "drug", "safety", "professionals.", "<tag3>"], "wordsA": ["The", "loan", "is", "secured", "by", "the", "Company's", "assets,", "excluding", "intellectual", "property."], "wordsB": ["The", "same", "data", "reviewed", "by", "the", "DSMB", "were", "subsequently", "brought", "in-house", "and", "examined", "by", "a", "committee", "of", "medical", "and", "drug", "safety", "professionals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p7_s1", "idA": "1316175_12_item7_p72_s2", "sentA": "We are also obligated to pay royalties on future net sales of products that are developed and approved as defined by this collaboration.", "sentB": "Blisibimod, a peptibody directed against BAFF, was developed as an alternative to antibodies and is produced in Escherichia coli bacterial culture versus antibodies that are produced in mammalian cell culture.", "type": 1, "words": ["<tag1>", "We", "are", "also", "obligated", "to", "pay", "royalties", "on", "future", "net", "sales", "of", "products", "that", "are", "developed", "and", "approved", "as", "defined", "by", "this", "collaboration.", "<tag2>", "Blisibimod,", "a", "peptibody", "directed", "against", "BAFF,", "was", "developed", "as", "an", "alternative", "to", "antibodies", "and", "is", "produced", "in", "Escherichia", "coli", "bacterial", "culture", "versus", "antibodies", "that", "are", "produced", "in", "mammalian", "cell", "culture.", "<tag3>"], "wordsA": ["We", "are", "also", "obligated", "to", "pay", "royalties", "on", "future", "net", "sales", "of", "products", "that", "are", "developed", "and", "approved", "as", "defined", "by", "this", "collaboration."], "wordsB": ["Blisibimod,", "a", "peptibody", "directed", "against", "BAFF,", "was", "developed", "as", "an", "alternative", "to", "antibodies", "and", "is", "produced", "in", "Escherichia", "coli", "bacterial", "culture", "versus", "antibodies", "that", "are", "produced", "in", "mammalian", "cell", "culture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_13_item7_p76_s2", "idA": "1316175_12_item7_p82_s1", "sentA": "We may elect to raise additional funds even before we need them if the conditions for raising capital are favorable.", "sentB": "For example, if we raise additional funds by issuing equity securities or by selling debt securities, if convertible, further dilution to our existing stockholders may result.", "type": 1, "words": ["<tag1>", "We", "may", "elect", "to", "raise", "additional", "funds", "even", "before", "we", "need", "them", "if", "the", "conditions", "for", "raising", "capital", "are", "favorable.", "<tag2>", "For", "example,", "if", "we", "raise", "additional", "funds", "by", "issuing", "equity", "securities", "or", "by", "selling", "debt", "securities,", "if", "convertible,", "further", "dilution", "to", "our", "existing", "stockholders", "may", "result.", "<tag3>"], "wordsA": ["We", "may", "elect", "to", "raise", "additional", "funds", "even", "before", "we", "need", "them", "if", "the", "conditions", "for", "raising", "capital", "are", "favorable."], "wordsB": ["For", "example,", "if", "we", "raise", "additional", "funds", "by", "issuing", "equity", "securities", "or", "by", "selling", "debt", "securities,", "if", "convertible,", "further", "dilution", "to", "our", "existing", "stockholders", "may", "result."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p52_s6", "idA": "1316175_13_item7_p0_s0", "sentA": "The following discussion and analysis should be read together with our financial statements and the related notes set forth under Item 8.", "sentB": "As a result, if factors change and different assumptions are used, the warrant liability and the change in estimated fair value could be materially different.", "type": 1, "words": ["<tag1>", "The", "following", "discussion", "and", "analysis", "should", "be", "read", "together", "with", "our", "financial", "statements", "and", "the", "related", "notes", "set", "forth", "under", "Item", "8.", "<tag2>", "As", "a", "result,", "if", "factors", "change", "and", "different", "assumptions", "are", "used,", "the", "warrant", "liability", "and", "the", "change", "in", "estimated", "fair", "value", "could", "be", "materially", "different.", "<tag3>"], "wordsA": ["The", "following", "discussion", "and", "analysis", "should", "be", "read", "together", "with", "our", "financial", "statements", "and", "the", "related", "notes", "set", "forth", "under", "Item", "8."], "wordsB": ["As", "a", "result,", "if", "factors", "change", "and", "different", "assumptions", "are", "used,", "the", "warrant", "liability", "and", "the", "change", "in", "estimated", "fair", "value", "could", "be", "materially", "different."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p28_s3", "idA": "1316175_13_item7_p11_s2", "sentA": "The BRIGHT-SC study will enroll approximately 48 patients with biopsy-proven IgAN who have proteinuria greater than one gram per 24 hours and are receiving standard of care.", "sentB": "The amendment serves to potentially transform BRIGHT-SC1 into one of two registration studies for blisibimod and adjust its endpoints to patients achieving less than 1 gram of proteinuria per 24 hours at 24 weeks.", "type": 1, "words": ["<tag1>", "The", "BRIGHT-SC", "study", "will", "enroll", "approximately", "48", "patients", "with", "biopsy-proven", "IgAN", "who", "have", "proteinuria", "greater", "than", "one", "gram", "per", "24", "hours", "and", "are", "receiving", "standard", "of", "care.", "<tag2>", "The", "amendment", "serves", "to", "potentially", "transform", "BRIGHT-SC1", "into", "one", "of", "two", "registration", "studies", "for", "blisibimod", "and", "adjust", "its", "endpoints", "to", "patients", "achieving", "less", "than", "1", "gram", "of", "proteinuria", "per", "24", "hours", "at", "24", "weeks.", "<tag3>"], "wordsA": ["The", "BRIGHT-SC", "study", "will", "enroll", "approximately", "48", "patients", "with", "biopsy-proven", "IgAN", "who", "have", "proteinuria", "greater", "than", "one", "gram", "per", "24", "hours", "and", "are", "receiving", "standard", "of", "care."], "wordsB": ["The", "amendment", "serves", "to", "potentially", "transform", "BRIGHT-SC1", "into", "one", "of", "two", "registration", "studies", "for", "blisibimod", "and", "adjust", "its", "endpoints", "to", "patients", "achieving", "less", "than", "1", "gram", "of", "proteinuria", "per", "24", "hours", "at", "24", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p28_s5", "idA": "1316175_13_item7_p11_s2", "sentA": "The BRIGHT-SC study will enroll approximately 48 patients with biopsy-proven IgAN who have proteinuria greater than one gram per 24 hours and are receiving standard of care.", "sentB": "To date 19 sites have been activated and are actively screening patients.", "type": 1, "words": ["<tag1>", "The", "BRIGHT-SC", "study", "will", "enroll", "approximately", "48", "patients", "with", "biopsy-proven", "IgAN", "who", "have", "proteinuria", "greater", "than", "one", "gram", "per", "24", "hours", "and", "are", "receiving", "standard", "of", "care.", "<tag2>", "To", "date", "19", "sites", "have", "been", "activated", "and", "are", "actively", "screening", "patients.", "<tag3>"], "wordsA": ["The", "BRIGHT-SC", "study", "will", "enroll", "approximately", "48", "patients", "with", "biopsy-proven", "IgAN", "who", "have", "proteinuria", "greater", "than", "one", "gram", "per", "24", "hours", "and", "are", "receiving", "standard", "of", "care."], "wordsB": ["To", "date", "19", "sites", "have", "been", "activated", "and", "are", "actively", "screening", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p50_s1", "idA": "1316175_13_item7_p19_s1", "sentA": "The establishment of this subsidiary was part of the Company s ongoing growth activities and strategic plan.", "sentB": "In the case of warrants recorded as liabilities, subsequent changes in estimated fair value are recorded in other income (expense) in the Company s statement of operations in each subsequent period.", "type": 1, "words": ["<tag1>", "The", "establishment", "of", "this", "subsidiary", "was", "part", "of", "the", "Company", "s", "ongoing", "growth", "activities", "and", "strategic", "plan.", "<tag2>", "In", "the", "case", "of", "warrants", "recorded", "as", "liabilities,", "subsequent", "changes", "in", "estimated", "fair", "value", "are", "recorded", "in", "other", "income", "(expense)", "in", "the", "Company", "s", "statement", "of", "operations", "in", "each", "subsequent", "period.", "<tag3>"], "wordsA": ["The", "establishment", "of", "this", "subsidiary", "was", "part", "of", "the", "Company", "s", "ongoing", "growth", "activities", "and", "strategic", "plan."], "wordsB": ["In", "the", "case", "of", "warrants", "recorded", "as", "liabilities,", "subsequent", "changes", "in", "estimated", "fair", "value", "are", "recorded", "in", "other", "income", "(expense)", "in", "the", "Company", "s", "statement", "of", "operations", "in", "each", "subsequent", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p50_s0", "idA": "1316175_13_item7_p19_s2", "sentA": "As of the date of this filing, we have never generated any revenue and have generated only interest income from cash and cash equivalents and short-term investments.", "sentB": "Warrants are recorded either as equity instruments or derivative liabilities at their estimated fair value at the date of issuance.", "type": 1, "words": ["<tag1>", "As", "of", "the", "date", "of", "this", "filing,", "we", "have", "never", "generated", "any", "revenue", "and", "have", "generated", "only", "interest", "income", "from", "cash", "and", "cash", "equivalents", "and", "short-term", "investments.", "<tag2>", "Warrants", "are", "recorded", "either", "as", "equity", "instruments", "or", "derivative", "liabilities", "at", "their", "estimated", "fair", "value", "at", "the", "date", "of", "issuance.", "<tag3>"], "wordsA": ["As", "of", "the", "date", "of", "this", "filing,", "we", "have", "never", "generated", "any", "revenue", "and", "have", "generated", "only", "interest", "income", "from", "cash", "and", "cash", "equivalents", "and", "short-term", "investments."], "wordsB": ["Warrants", "are", "recorded", "either", "as", "equity", "instruments", "or", "derivative", "liabilities", "at", "their", "estimated", "fair", "value", "at", "the", "date", "of", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p16_s0", "idA": "1316175_13_item7_p21_s2", "sentA": "We intend to seek to generate revenue from a combination of product sales, up-front fees and milestone payments in connection with collaborative or strategic relationships and royalties resulting from the licensing of the commercial rights to our intellectual property.", "sentB": "Lupus patients suffer from a chronic autoimmune disease, where an inappropriate or abnormal immune response often leads to severe skin rash, fatigue, joint pain, ulceration, major kidney complications, including proteinuria, and cardiovascular disease.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "seek", "to", "generate", "revenue", "from", "a", "combination", "of", "product", "sales,", "up-front", "fees", "and", "milestone", "payments", "in", "connection", "with", "collaborative", "or", "strategic", "relationships", "and", "royalties", "resulting", "from", "the", "licensing", "of", "the", "commercial", "rights", "to", "our", "intellectual", "property.", "<tag2>", "Lupus", "patients", "suffer", "from", "a", "chronic", "autoimmune", "disease,", "where", "an", "inappropriate", "or", "abnormal", "immune", "response", "often", "leads", "to", "severe", "skin", "rash,", "fatigue,", "joint", "pain,", "ulceration,", "major", "kidney", "complications,", "including", "proteinuria,", "and", "cardiovascular", "disease.", "<tag3>"], "wordsA": ["We", "intend", "to", "seek", "to", "generate", "revenue", "from", "a", "combination", "of", "product", "sales,", "up-front", "fees", "and", "milestone", "payments", "in", "connection", "with", "collaborative", "or", "strategic", "relationships", "and", "royalties", "resulting", "from", "the", "licensing", "of", "the", "commercial", "rights", "to", "our", "intellectual", "property."], "wordsB": ["Lupus", "patients", "suffer", "from", "a", "chronic", "autoimmune", "disease,", "where", "an", "inappropriate", "or", "abnormal", "immune", "response", "often", "leads", "to", "severe", "skin", "rash,", "fatigue,", "joint", "pain,", "ulceration,", "major", "kidney", "complications,", "including", "proteinuria,", "and", "cardiovascular", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p13_s0", "idA": "1316175_13_item7_p24_s0", "sentA": "Historically, our clinical development costs have included costs for preclinical and clinical studies.", "sentB": "Blisibimod inhibits both soluble and membrane-bound BAFF.", "type": 1, "words": ["<tag1>", "Historically,", "our", "clinical", "development", "costs", "have", "included", "costs", "for", "preclinical", "and", "clinical", "studies.", "<tag2>", "Blisibimod", "inhibits", "both", "soluble", "and", "membrane-bound", "BAFF.", "<tag3>"], "wordsA": ["Historically,", "our", "clinical", "development", "costs", "have", "included", "costs", "for", "preclinical", "and", "clinical", "studies."], "wordsB": ["Blisibimod", "inhibits", "both", "soluble", "and", "membrane-bound", "BAFF."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p1_s0", "idA": "1316175_13_item7_p24_s0", "sentA": "Historically, our clinical development costs have included costs for preclinical and clinical studies.", "sentB": "Consolidated Financial Statements and Supplementary Data.", "type": 1, "words": ["<tag1>", "Historically,", "our", "clinical", "development", "costs", "have", "included", "costs", "for", "preclinical", "and", "clinical", "studies.", "<tag2>", "Consolidated", "Financial", "Statements", "and", "Supplementary", "Data.", "<tag3>"], "wordsA": ["Historically,", "our", "clinical", "development", "costs", "have", "included", "costs", "for", "preclinical", "and", "clinical", "studies."], "wordsB": ["Consolidated", "Financial", "Statements", "and", "Supplementary", "Data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p11_s1", "idA": "1316175_13_item7_p30_s1", "sentA": "We intend to fund our clinical studies with existing cash and proceeds from potential future debt and equity offerings.", "sentB": "The potential role of BAFF inhibition and associated reductions in B-cell and plasma cell numbers in lupus and rheumatoid arthritis has been validated in multiple clinical studies with blisibimod and other BAFF antagonists.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "fund", "our", "clinical", "studies", "with", "existing", "cash", "and", "proceeds", "from", "potential", "future", "debt", "and", "equity", "offerings.", "<tag2>", "The", "potential", "role", "of", "BAFF", "inhibition", "and", "associated", "reductions", "in", "B-cell", "and", "plasma", "cell", "numbers", "in", "lupus", "and", "rheumatoid", "arthritis", "has", "been", "validated", "in", "multiple", "clinical", "studies", "with", "blisibimod", "and", "other", "BAFF", "antagonists.", "<tag3>"], "wordsA": ["We", "intend", "to", "fund", "our", "clinical", "studies", "with", "existing", "cash", "and", "proceeds", "from", "potential", "future", "debt", "and", "equity", "offerings."], "wordsB": ["The", "potential", "role", "of", "BAFF", "inhibition", "and", "associated", "reductions", "in", "B-cell", "and", "plasma", "cell", "numbers", "in", "lupus", "and", "rheumatoid", "arthritis", "has", "been", "validated", "in", "multiple", "clinical", "studies", "with", "blisibimod", "and", "other", "BAFF", "antagonists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p7_s1", "idA": "1316175_13_item7_p33_s3", "sentA": "Payments under the contracts depend on factors such as the successful enrollment of patients or the completion of clinical study milestones.", "sentB": "Elevated BAFF is also reported in hematological diseases such as multiple myeloma and idiopathic thrombocytopenia purpura.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones.", "<tag2>", "Elevated", "BAFF", "is", "also", "reported", "in", "hematological", "diseases", "such", "as", "multiple", "myeloma", "and", "idiopathic", "thrombocytopenia", "purpura.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "successful", "enrollment", "of", "patients", "or", "the", "completion", "of", "clinical", "study", "milestones."], "wordsB": ["Elevated", "BAFF", "is", "also", "reported", "in", "hematological", "diseases", "such", "as", "multiple", "myeloma", "and", "idiopathic", "thrombocytopenia", "purpura."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p22_s0", "idA": "1316175_13_item7_p33_s5", "sentA": "If timelines or contracts are modified based upon changes to the clinical study design or scope of work to be performed, we modify our estimates of accrued expenses accordingly on a prospective basis.", "sentB": "A futility analysis of clinical study is planned to be conducted by an independent unblinded statistician in mid-2014 after a minimum of 100 subjects have completed 24 weeks of treatment to confirm the clinical and commercial assumptions of the design of this study.", "type": 1, "words": ["<tag1>", "If", "timelines", "or", "contracts", "are", "modified", "based", "upon", "changes", "to", "the", "clinical", "study", "design", "or", "scope", "of", "work", "to", "be", "performed,", "we", "modify", "our", "estimates", "of", "accrued", "expenses", "accordingly", "on", "a", "prospective", "basis.", "<tag2>", "A", "futility", "analysis", "of", "clinical", "study", "is", "planned", "to", "be", "conducted", "by", "an", "independent", "unblinded", "statistician", "in", "mid-2014", "after", "a", "minimum", "of", "100", "subjects", "have", "completed", "24", "weeks", "of", "treatment", "to", "confirm", "the", "clinical", "and", "commercial", "assumptions", "of", "the", "design", "of", "this", "study.", "<tag3>"], "wordsA": ["If", "timelines", "or", "contracts", "are", "modified", "based", "upon", "changes", "to", "the", "clinical", "study", "design", "or", "scope", "of", "work", "to", "be", "performed,", "we", "modify", "our", "estimates", "of", "accrued", "expenses", "accordingly", "on", "a", "prospective", "basis."], "wordsB": ["A", "futility", "analysis", "of", "clinical", "study", "is", "planned", "to", "be", "conducted", "by", "an", "independent", "unblinded", "statistician", "in", "mid-2014", "after", "a", "minimum", "of", "100", "subjects", "have", "completed", "24", "weeks", "of", "treatment", "to", "confirm", "the", "clinical", "and", "commercial", "assumptions", "of", "the", "design", "of", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p80_s3", "idA": "1316175_13_item7_p42_s0", "sentA": "We base our accruals related to clinical studies on our estimates of the services received and efforts expended pursuant to contracts with multiple research institutions and CROs that conduct and manage clinical studies on our behalf.", "sentB": "In April 2013, we increased the amount of securities that may be issued under the registration statement by $3.2 million through the filing of a post-effective amendment pursuant to Rule 462(b) of the Securities Act.", "type": 1, "words": ["<tag1>", "We", "base", "our", "accruals", "related", "to", "clinical", "studies", "on", "our", "estimates", "of", "the", "services", "received", "and", "efforts", "expended", "pursuant", "to", "contracts", "with", "multiple", "research", "institutions", "and", "CROs", "that", "conduct", "and", "manage", "clinical", "studies", "on", "our", "behalf.", "<tag2>", "In", "April", "2013,", "we", "increased", "the", "amount", "of", "securities", "that", "may", "be", "issued", "under", "the", "registration", "statement", "by", "$3.2", "million", "through", "the", "filing", "of", "a", "post-effective", "amendment", "pursuant", "to", "Rule", "462(b)", "of", "the", "Securities", "Act.", "<tag3>"], "wordsA": ["We", "base", "our", "accruals", "related", "to", "clinical", "studies", "on", "our", "estimates", "of", "the", "services", "received", "and", "efforts", "expended", "pursuant", "to", "contracts", "with", "multiple", "research", "institutions", "and", "CROs", "that", "conduct", "and", "manage", "clinical", "studies", "on", "our", "behalf."], "wordsB": ["In", "April", "2013,", "we", "increased", "the", "amount", "of", "securities", "that", "may", "be", "issued", "under", "the", "registration", "statement", "by", "$3.2", "million", "through", "the", "filing", "of", "a", "post-effective", "amendment", "pursuant", "to", "Rule", "462(b)", "of", "the", "Securities", "Act."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p59_s1", "idA": "1316175_13_item7_p45_s0", "sentA": "General and administrative expenses decreased in 2012 to 2011 primarily due to lower legal cost associated with patent prosecution of varespladib as a result of the termination of the VISTA-16 study in March 2012.", "sentB": "Excluding the non-cash expense associated with stock-based compensation, general and administrative expense decreased in 2013 from 2012 by approximately $1.4 million and reflected our ongoing cost reduction efforts that led to decreases in professional, consulting and overhead expenses.", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "decreased", "in", "2012", "to", "2011", "primarily", "due", "to", "lower", "legal", "cost", "associated", "with", "patent", "prosecution", "of", "varespladib", "as", "a", "result", "of", "the", "termination", "of", "the", "VISTA-16", "study", "in", "March", "2012.", "<tag2>", "Excluding", "the", "non-cash", "expense", "associated", "with", "stock-based", "compensation,", "general", "and", "administrative", "expense", "decreased", "in", "2013", "from", "2012", "by", "approximately", "$1.4", "million", "and", "reflected", "our", "ongoing", "cost", "reduction", "efforts", "that", "led", "to", "decreases", "in", "professional,", "consulting", "and", "overhead", "expenses.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "decreased", "in", "2012", "to", "2011", "primarily", "due", "to", "lower", "legal", "cost", "associated", "with", "patent", "prosecution", "of", "varespladib", "as", "a", "result", "of", "the", "termination", "of", "the", "VISTA-16", "study", "in", "March", "2012."], "wordsB": ["Excluding", "the", "non-cash", "expense", "associated", "with", "stock-based", "compensation,", "general", "and", "administrative", "expense", "decreased", "in", "2013", "from", "2012", "by", "approximately", "$1.4", "million", "and", "reflected", "our", "ongoing", "cost", "reduction", "efforts", "that", "led", "to", "decreases", "in", "professional,", "consulting", "and", "overhead", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p28_s2", "idA": "1316175_13_item7_p46_s0", "sentA": "Other expense recorded in 2012 is a result of net loss realized from foreign currency exchange fluctuations.", "sentB": "As a result of discussion with the US FDA on the potential SE of proteinuria as the endpoint for Subpart E approval for blisibimod, the Company amended the BRIGHT-SC1 study endpoints during the fourth quarter of 2013.", "type": 1, "words": ["<tag1>", "Other", "expense", "recorded", "in", "2012", "is", "a", "result", "of", "net", "loss", "realized", "from", "foreign", "currency", "exchange", "fluctuations.", "<tag2>", "As", "a", "result", "of", "discussion", "with", "the", "US", "FDA", "on", "the", "potential", "SE", "of", "proteinuria", "as", "the", "endpoint", "for", "Subpart", "E", "approval", "for", "blisibimod,", "the", "Company", "amended", "the", "BRIGHT-SC1", "study", "endpoints", "during", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["Other", "expense", "recorded", "in", "2012", "is", "a", "result", "of", "net", "loss", "realized", "from", "foreign", "currency", "exchange", "fluctuations."], "wordsB": ["As", "a", "result", "of", "discussion", "with", "the", "US", "FDA", "on", "the", "potential", "SE", "of", "proteinuria", "as", "the", "endpoint", "for", "Subpart", "E", "approval", "for", "blisibimod,", "the", "Company", "amended", "the", "BRIGHT-SC1", "study", "endpoints", "during", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p19_s0", "idA": "1316175_13_item7_p4_s0", "sentA": "Blisibimod is a peptibody antagonist of the BAFF cytokine that is initially being developed as a treatment for lupus.", "sentB": "The blisibimod product is designed for at-home, self-administration and is presented as a pre-filled syringe for subcutaneous administration.", "type": 1, "words": ["<tag1>", "Blisibimod", "is", "a", "peptibody", "antagonist", "of", "the", "BAFF", "cytokine", "that", "is", "initially", "being", "developed", "as", "a", "treatment", "for", "lupus.", "<tag2>", "The", "blisibimod", "product", "is", "designed", "for", "at-home,", "self-administration", "and", "is", "presented", "as", "a", "pre-filled", "syringe", "for", "subcutaneous", "administration.", "<tag3>"], "wordsA": ["Blisibimod", "is", "a", "peptibody", "antagonist", "of", "the", "BAFF", "cytokine", "that", "is", "initially", "being", "developed", "as", "a", "treatment", "for", "lupus."], "wordsB": ["The", "blisibimod", "product", "is", "designed", "for", "at-home,", "self-administration", "and", "is", "presented", "as", "a", "pre-filled", "syringe", "for", "subcutaneous", "administration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p22_s1", "idA": "1316175_13_item7_p51_s0", "sentA": "Cash, cash equivalents and investments consist of the following (in millions):", "sentB": "This futility analysis is not intended to provide any rules for stopping for overwhelming efficacy, change in study sample size, or alteration of the study design.", "type": 1, "words": ["<tag1>", "Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "millions):", "<tag2>", "This", "futility", "analysis", "is", "not", "intended", "to", "provide", "any", "rules", "for", "stopping", "for", "overwhelming", "efficacy,", "change", "in", "study", "sample", "size,", "or", "alteration", "of", "the", "study", "design.", "<tag3>"], "wordsA": ["Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "millions):"], "wordsB": ["This", "futility", "analysis", "is", "not", "intended", "to", "provide", "any", "rules", "for", "stopping", "for", "overwhelming", "efficacy,", "change", "in", "study", "sample", "size,", "or", "alteration", "of", "the", "study", "design."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p52_s2", "idA": "1316175_13_item7_p51_s0", "sentA": "Cash, cash equivalents and investments consist of the following (in millions):", "sentB": "The expected life of the warrants is assumed to be equivalent to their remaining contractual term.", "type": 1, "words": ["<tag1>", "Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "millions):", "<tag2>", "The", "expected", "life", "of", "the", "warrants", "is", "assumed", "to", "be", "equivalent", "to", "their", "remaining", "contractual", "term.", "<tag3>"], "wordsA": ["Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "millions):"], "wordsB": ["The", "expected", "life", "of", "the", "warrants", "is", "assumed", "to", "be", "equivalent", "to", "their", "remaining", "contractual", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p81_s1", "idA": "1316175_13_item7_p53_s0", "sentA": "We filed a universal shelf registration statement with the SEC on Form S-3 (File No. 333-179043) on January 17, 2012, which was declared effective on January 24, 2012, for the proposed offering from time to time of up to $100.0 million of our securities, including common stock, preferred stock, debt securities and/or warrants.", "sentB": "On November 15, 2013, we registered $25.0 million under the registration statement for the Cowen ATM.", "type": 1, "words": ["<tag1>", "We", "filed", "a", "universal", "shelf", "registration", "statement", "with", "the", "SEC", "on", "Form", "S-3", "(File", "No.", "333-179043)", "on", "January", "17,", "2012,", "which", "was", "declared", "effective", "on", "January", "24,", "2012,", "for", "the", "proposed", "offering", "from", "time", "to", "time", "of", "up", "to", "$100.0", "million", "of", "our", "securities,", "including", "common", "stock,", "preferred", "stock,", "debt", "securities", "and/or", "warrants.", "<tag2>", "On", "November", "15,", "2013,", "we", "registered", "$25.0", "million", "under", "the", "registration", "statement", "for", "the", "Cowen", "ATM.", "<tag3>"], "wordsA": ["We", "filed", "a", "universal", "shelf", "registration", "statement", "with", "the", "SEC", "on", "Form", "S-3", "(File", "No.", "333-179043)", "on", "January", "17,", "2012,", "which", "was", "declared", "effective", "on", "January", "24,", "2012,", "for", "the", "proposed", "offering", "from", "time", "to", "time", "of", "up", "to", "$100.0", "million", "of", "our", "securities,", "including", "common", "stock,", "preferred", "stock,", "debt", "securities", "and/or", "warrants."], "wordsB": ["On", "November", "15,", "2013,", "we", "registered", "$25.0", "million", "under", "the", "registration", "statement", "for", "the", "Cowen", "ATM."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p27_s1", "idA": "1316175_13_item7_p54_s0", "sentA": "We may issue securities in the future based on market conditions or other circumstances.", "sentB": "We initiated our BRIGHT-SC1 study in the second quarter of 2013.", "type": 1, "words": ["<tag1>", "We", "may", "issue", "securities", "in", "the", "future", "based", "on", "market", "conditions", "or", "other", "circumstances.", "<tag2>", "We", "initiated", "our", "BRIGHT-SC1", "study", "in", "the", "second", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["We", "may", "issue", "securities", "in", "the", "future", "based", "on", "market", "conditions", "or", "other", "circumstances."], "wordsB": ["We", "initiated", "our", "BRIGHT-SC1", "study", "in", "the", "second", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p29_s2", "idA": "1316175_13_item7_p54_s0", "sentA": "We may issue securities in the future based on market conditions or other circumstances.", "sentB": "We anticipate feedback regarding our IgA development from the FDA in the first quarter of 2014.", "type": 1, "words": ["<tag1>", "We", "may", "issue", "securities", "in", "the", "future", "based", "on", "market", "conditions", "or", "other", "circumstances.", "<tag2>", "We", "anticipate", "feedback", "regarding", "our", "IgA", "development", "from", "the", "FDA", "in", "the", "first", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "may", "issue", "securities", "in", "the", "future", "based", "on", "market", "conditions", "or", "other", "circumstances."], "wordsB": ["We", "anticipate", "feedback", "regarding", "our", "IgA", "development", "from", "the", "FDA", "in", "the", "first", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p82_s0", "idA": "1316175_13_item7_p55_s2", "sentA": "We have not sold any shares of our common stock pursuant to the Agreement, which was terminated January 24, 2013.", "sentB": "Based on the requirements of Form S-3, however, there are certain factors, such as volume of trading in our common stock and our stock price, which limit the amount that can be raised in a short period of time through Purchase Agreement and registration statements described above.", "type": 1, "words": ["<tag1>", "We", "have", "not", "sold", "any", "shares", "of", "our", "common", "stock", "pursuant", "to", "the", "Agreement,", "which", "was", "terminated", "January", "24,", "2013.", "<tag2>", "Based", "on", "the", "requirements", "of", "Form", "S-3,", "however,", "there", "are", "certain", "factors,", "such", "as", "volume", "of", "trading", "in", "our", "common", "stock", "and", "our", "stock", "price,", "which", "limit", "the", "amount", "that", "can", "be", "raised", "in", "a", "short", "period", "of", "time", "through", "Purchase", "Agreement", "and", "registration", "statements", "described", "above.", "<tag3>"], "wordsA": ["We", "have", "not", "sold", "any", "shares", "of", "our", "common", "stock", "pursuant", "to", "the", "Agreement,", "which", "was", "terminated", "January", "24,", "2013."], "wordsB": ["Based", "on", "the", "requirements", "of", "Form", "S-3,", "however,", "there", "are", "certain", "factors,", "such", "as", "volume", "of", "trading", "in", "our", "common", "stock", "and", "our", "stock", "price,", "which", "limit", "the", "amount", "that", "can", "be", "raised", "in", "a", "short", "period", "of", "time", "through", "Purchase", "Agreement", "and", "registration", "statements", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p70_s4", "idA": "1316175_13_item7_p55_s3", "sentA": "This facility is no longer available for use.", "sentB": "Therefore, there is no mark-to-market adjustment on warrant liability recorded in the three months ended March 31, 2013.", "type": 1, "words": ["<tag1>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag2>", "Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "three", "months", "ended", "March", "31,", "2013.", "<tag3>"], "wordsA": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "wordsB": ["Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "three", "months", "ended", "March", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p71_s4", "idA": "1316175_13_item7_p55_s3", "sentA": "This facility is no longer available for use.", "sentB": "Therefore, there is no mark-to-market adjustment on warrant liability recorded in the three months ended June 30, 2013.", "type": 1, "words": ["<tag1>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag2>", "Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "three", "months", "ended", "June", "30,", "2013.", "<tag3>"], "wordsA": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "wordsB": ["Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "three", "months", "ended", "June", "30,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p72_s4", "idA": "1316175_13_item7_p55_s3", "sentA": "This facility is no longer available for use.", "sentB": "Therefore, there is no mark-to-market adjustment on warrant liability recorded in the six months ended June 30, 2013.", "type": 1, "words": ["<tag1>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag2>", "Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "six", "months", "ended", "June", "30,", "2013.", "<tag3>"], "wordsA": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "wordsB": ["Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "six", "months", "ended", "June", "30,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p73_s5", "idA": "1316175_13_item7_p55_s3", "sentA": "This facility is no longer available for use.", "sentB": "Therefore, there is no mark-to-market adjustment on warrant liability recorded in the three months ended September 30, 2013.", "type": 1, "words": ["<tag1>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag2>", "Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "three", "months", "ended", "September", "30,", "2013.", "<tag3>"], "wordsA": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "wordsB": ["Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "three", "months", "ended", "September", "30,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p74_s5", "idA": "1316175_13_item7_p55_s3", "sentA": "This facility is no longer available for use.", "sentB": "Therefore, there is no mark-to-market adjustment on warrant liability recorded in the nine months ended September 30, 2013.", "type": 1, "words": ["<tag1>", "This", "facility", "is", "no", "longer", "available", "for", "use.", "<tag2>", "Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "nine", "months", "ended", "September", "30,", "2013.", "<tag3>"], "wordsA": ["This", "facility", "is", "no", "longer", "available", "for", "use."], "wordsB": ["Therefore,", "there", "is", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "nine", "months", "ended", "September", "30,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p16_s1", "idA": "1316175_13_item7_p5_s0", "sentA": "BLyS, also known as B-cell activating factor, or BAFF, is a tumor necrosis family member and is critical to the development, maintenance and survival of B-cells.", "sentB": "Inhibition of BAFF is believed to reduce survival of B-cells and plasma cells and autoantibodies, leading to a reduction in severity of disease and resolution of lupus symptoms.", "type": 1, "words": ["<tag1>", "BLyS,", "also", "known", "as", "B-cell", "activating", "factor,", "or", "BAFF,", "is", "a", "tumor", "necrosis", "family", "member", "and", "is", "critical", "to", "the", "development,", "maintenance", "and", "survival", "of", "B-cells.", "<tag2>", "Inhibition", "of", "BAFF", "is", "believed", "to", "reduce", "survival", "of", "B-cells", "and", "plasma", "cells", "and", "autoantibodies,", "leading", "to", "a", "reduction", "in", "severity", "of", "disease", "and", "resolution", "of", "lupus", "symptoms.", "<tag3>"], "wordsA": ["BLyS,", "also", "known", "as", "B-cell", "activating", "factor,", "or", "BAFF,", "is", "a", "tumor", "necrosis", "family", "member", "and", "is", "critical", "to", "the", "development,", "maintenance", "and", "survival", "of", "B-cells."], "wordsB": ["Inhibition", "of", "BAFF", "is", "believed", "to", "reduce", "survival", "of", "B-cells", "and", "plasma", "cells", "and", "autoantibodies,", "leading", "to", "a", "reduction", "in", "severity", "of", "disease", "and", "resolution", "of", "lupus", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p23_s1", "idA": "1316175_13_item7_p67_s4", "sentA": "Thereafter, the loan is being repaid in 30 equal monthly installments of approximately $1.0 million, at the initial interest rate.", "sentB": "An independent DSMB will convene to review the study at the end of March 2014 and mid-July 2014.", "type": 1, "words": ["<tag1>", "Thereafter,", "the", "loan", "is", "being", "repaid", "in", "30", "equal", "monthly", "installments", "of", "approximately", "$1.0", "million,", "at", "the", "initial", "interest", "rate.", "<tag2>", "An", "independent", "DSMB", "will", "convene", "to", "review", "the", "study", "at", "the", "end", "of", "March", "2014", "and", "mid-July", "2014.", "<tag3>"], "wordsA": ["Thereafter,", "the", "loan", "is", "being", "repaid", "in", "30", "equal", "monthly", "installments", "of", "approximately", "$1.0", "million,", "at", "the", "initial", "interest", "rate."], "wordsB": ["An", "independent", "DSMB", "will", "convene", "to", "review", "the", "study", "at", "the", "end", "of", "March", "2014", "and", "mid-July", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p51_s1", "idA": "1316175_13_item7_p67_s4", "sentA": "Thereafter, the loan is being repaid in 30 equal monthly installments of approximately $1.0 million, at the initial interest rate.", "sentB": "Inherent in this model are assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield.", "type": 1, "words": ["<tag1>", "Thereafter,", "the", "loan", "is", "being", "repaid", "in", "30", "equal", "monthly", "installments", "of", "approximately", "$1.0", "million,", "at", "the", "initial", "interest", "rate.", "<tag2>", "Inherent", "in", "this", "model", "are", "assumptions", "related", "to", "expected", "stock", "price", "volatility,", "expected", "life,", "risk-free", "interest", "rate", "and", "dividend", "yield.", "<tag3>"], "wordsA": ["Thereafter,", "the", "loan", "is", "being", "repaid", "in", "30", "equal", "monthly", "installments", "of", "approximately", "$1.0", "million,", "at", "the", "initial", "interest", "rate."], "wordsB": ["Inherent", "in", "this", "model", "are", "assumptions", "related", "to", "expected", "stock", "price", "volatility,", "expected", "life,", "risk-free", "interest", "rate", "and", "dividend", "yield."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p51_s0", "idA": "1316175_13_item7_p67_s5", "sentA": "We will be obligated to pay an end of the term charge of $0.9 million, which is being expensed over the term of the Loan Agreement using the effective interest rate.", "sentB": "The warrants are measured at estimated fair value using the Black Scholes valuation model, which is based, in part, upon inputs for which there is little or no observable market data, requiring the Company to develop its own assumptions.", "type": 1, "words": ["<tag1>", "We", "will", "be", "obligated", "to", "pay", "an", "end", "of", "the", "term", "charge", "of", "$0.9", "million,", "which", "is", "being", "expensed", "over", "the", "term", "of", "the", "Loan", "Agreement", "using", "the", "effective", "interest", "rate.", "<tag2>", "The", "warrants", "are", "measured", "at", "estimated", "fair", "value", "using", "the", "Black", "Scholes", "valuation", "model,", "which", "is", "based,", "in", "part,", "upon", "inputs", "for", "which", "there", "is", "little", "or", "no", "observable", "market", "data,", "requiring", "the", "Company", "to", "develop", "its", "own", "assumptions.", "<tag3>"], "wordsA": ["We", "will", "be", "obligated", "to", "pay", "an", "end", "of", "the", "term", "charge", "of", "$0.9", "million,", "which", "is", "being", "expensed", "over", "the", "term", "of", "the", "Loan", "Agreement", "using", "the", "effective", "interest", "rate."], "wordsB": ["The", "warrants", "are", "measured", "at", "estimated", "fair", "value", "using", "the", "Black", "Scholes", "valuation", "model,", "which", "is", "based,", "in", "part,", "upon", "inputs", "for", "which", "there", "is", "little", "or", "no", "observable", "market", "data,", "requiring", "the", "Company", "to", "develop", "its", "own", "assumptions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_14_item7_p25_s1", "idA": "1316175_13_item7_p9_s2", "sentA": "The Phase 3 studies (CHABLIS-SC1 and CHABLIS-SC2) are planned to be multicenter, placebo-controlled, randomized, double-blind studies designed to evaluate the efficacy, safety, tolerability and immunogenicity of blisibimod in patients with clinically active SLE (SELENA-SLEDAI 10) who require corticosteroid therapy in addition to standard-of-care for treatment of their disease.", "sentB": "This study is planned to enroll patients with clinical diagnosis of lupus with or without renal disease including patients with glomerulonephritis and patients who may have had a previous diagnosis of lupus nephritis who continue to have active elements of lupus.", "type": 1, "words": ["<tag1>", "The", "Phase", "3", "studies", "(CHABLIS-SC1", "and", "CHABLIS-SC2)", "are", "planned", "to", "be", "multicenter,", "placebo-controlled,", "randomized,", "double-blind", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "tolerability", "and", "immunogenicity", "of", "blisibimod", "in", "patients", "with", "clinically", "active", "SLE", "(SELENA-SLEDAI", "10)", "who", "require", "corticosteroid", "therapy", "in", "addition", "to", "standard-of-care", "for", "treatment", "of", "their", "disease.", "<tag2>", "This", "study", "is", "planned", "to", "enroll", "patients", "with", "clinical", "diagnosis", "of", "lupus", "with", "or", "without", "renal", "disease", "including", "patients", "with", "glomerulonephritis", "and", "patients", "who", "may", "have", "had", "a", "previous", "diagnosis", "of", "lupus", "nephritis", "who", "continue", "to", "have", "active", "elements", "of", "lupus.", "<tag3>"], "wordsA": ["The", "Phase", "3", "studies", "(CHABLIS-SC1", "and", "CHABLIS-SC2)", "are", "planned", "to", "be", "multicenter,", "placebo-controlled,", "randomized,", "double-blind", "studies", "designed", "to", "evaluate", "the", "efficacy,", "safety,", "tolerability", "and", "immunogenicity", "of", "blisibimod", "in", "patients", "with", "clinically", "active", "SLE", "(SELENA-SLEDAI", "10)", "who", "require", "corticosteroid", "therapy", "in", "addition", "to", "standard-of-care", "for", "treatment", "of", "their", "disease."], "wordsB": ["This", "study", "is", "planned", "to", "enroll", "patients", "with", "clinical", "diagnosis", "of", "lupus", "with", "or", "without", "renal", "disease", "including", "patients", "with", "glomerulonephritis", "and", "patients", "who", "may", "have", "had", "a", "previous", "diagnosis", "of", "lupus", "nephritis", "who", "continue", "to", "have", "active", "elements", "of", "lupus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p8_s7", "idA": "1316175_14_item7_p20_s0", "sentA": "In the third quarter of 2012 at an End of Phase 2 meeting with the FDA, we presented the results of the PEARL-SC clinical study and our plans for Phase 3 registration studies in patients with active lupus.", "sentB": "These characteristics were associated with improved outcomes in both our previous Phase 2 clinical study as well as in two large Phase 3 studies conducted with another BAFF-inhibitors, belimumab (Benlysta) and, more recently, tabalumab.", "type": 1, "words": ["<tag1>", "In", "the", "third", "quarter", "of", "2012", "at", "an", "End", "of", "Phase", "2", "meeting", "with", "the", "FDA,", "we", "presented", "the", "results", "of", "the", "PEARL-SC", "clinical", "study", "and", "our", "plans", "for", "Phase", "3", "registration", "studies", "in", "patients", "with", "active", "lupus.", "<tag2>", "These", "characteristics", "were", "associated", "with", "improved", "outcomes", "in", "both", "our", "previous", "Phase", "2", "clinical", "study", "as", "well", "as", "in", "two", "large", "Phase", "3", "studies", "conducted", "with", "another", "BAFF-inhibitors,", "belimumab", "(Benlysta)", "and,", "more", "recently,", "tabalumab.", "<tag3>"], "wordsA": ["In", "the", "third", "quarter", "of", "2012", "at", "an", "End", "of", "Phase", "2", "meeting", "with", "the", "FDA,", "we", "presented", "the", "results", "of", "the", "PEARL-SC", "clinical", "study", "and", "our", "plans", "for", "Phase", "3", "registration", "studies", "in", "patients", "with", "active", "lupus."], "wordsB": ["These", "characteristics", "were", "associated", "with", "improved", "outcomes", "in", "both", "our", "previous", "Phase", "2", "clinical", "study", "as", "well", "as", "in", "two", "large", "Phase", "3", "studies", "conducted", "with", "another", "BAFF-inhibitors,", "belimumab", "(Benlysta)", "and,", "more", "recently,", "tabalumab."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p41_s1", "idA": "1316175_14_item7_p25_s0", "sentA": "Following recent input from the FDA, we plan to submit a second pivotal study to the FDA in the first quarter of 2014.", "sentB": "Changes in assumptions or judgments or changes to the elements in an arrangement could cause a material increase or decrease in the amount of revenue that we report in a particular period.", "type": 1, "words": ["<tag1>", "Following", "recent", "input", "from", "the", "FDA,", "we", "plan", "to", "submit", "a", "second", "pivotal", "study", "to", "the", "FDA", "in", "the", "first", "quarter", "of", "2014.", "<tag2>", "Changes", "in", "assumptions", "or", "judgments", "or", "changes", "to", "the", "elements", "in", "an", "arrangement", "could", "cause", "a", "material", "increase", "or", "decrease", "in", "the", "amount", "of", "revenue", "that", "we", "report", "in", "a", "particular", "period.", "<tag3>"], "wordsA": ["Following", "recent", "input", "from", "the", "FDA,", "we", "plan", "to", "submit", "a", "second", "pivotal", "study", "to", "the", "FDA", "in", "the", "first", "quarter", "of", "2014."], "wordsB": ["Changes", "in", "assumptions", "or", "judgments", "or", "changes", "to", "the", "elements", "in", "an", "arrangement", "could", "cause", "a", "material", "increase", "or", "decrease", "in", "the", "amount", "of", "revenue", "that", "we", "report", "in", "a", "particular", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p33_s1", "idA": "1316175_14_item7_p28_s5", "sentA": "To date 19 sites have been activated and are actively screening patients.", "sentB": "We will recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable, and collectability is reasonably assured.", "type": 1, "words": ["<tag1>", "To", "date", "19", "sites", "have", "been", "activated", "and", "are", "actively", "screening", "patients.", "<tag2>", "We", "will", "recognize", "revenue", "when", "persuasive", "evidence", "of", "an", "arrangement", "exists,", "delivery", "has", "occurred", "or", "services", "have", "been", "rendered,", "the", "price", "is", "fixed", "or", "determinable,", "and", "collectability", "is", "reasonably", "assured.", "<tag3>"], "wordsA": ["To", "date", "19", "sites", "have", "been", "activated", "and", "are", "actively", "screening", "patients."], "wordsB": ["We", "will", "recognize", "revenue", "when", "persuasive", "evidence", "of", "an", "arrangement", "exists,", "delivery", "has", "occurred", "or", "services", "have", "been", "rendered,", "the", "price", "is", "fixed", "or", "determinable,", "and", "collectability", "is", "reasonably", "assured."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p32_s1", "idA": "1316175_14_item7_p33_s1", "sentA": "We expense research and development costs as they are incurred.", "sentB": "We will recognize revenue in accordance with FASB Accounting Standards Codification, or ASC 605 Revenue Recognition , subtopic ASC 605-25 Revenue with Multiple Element Arrangements and subtopic ASC 605-28 Revenue Recognition-Milestone Method , which provide accounting guidance for revenue recognition for arrangements with multiple deliverables and guidance on defining the milestone and determining when the use of the milestone method of revenue recognition for research and development transactions is appropriate, respectively.", "type": 1, "words": ["<tag1>", "We", "expense", "research", "and", "development", "costs", "as", "they", "are", "incurred.", "<tag2>", "We", "will", "recognize", "revenue", "in", "accordance", "with", "FASB", "Accounting", "Standards", "Codification,", "or", "ASC", "605", "Revenue", "Recognition", ",", "subtopic", "ASC", "605-25", "Revenue", "with", "Multiple", "Element", "Arrangements", "and", "subtopic", "ASC", "605-28", "Revenue", "Recognition-Milestone", "Method", ",", "which", "provide", "accounting", "guidance", "for", "revenue", "recognition", "for", "arrangements", "with", "multiple", "deliverables", "and", "guidance", "on", "defining", "the", "milestone", "and", "determining", "when", "the", "use", "of", "the", "milestone", "method", "of", "revenue", "recognition", "for", "research", "and", "development", "transactions", "is", "appropriate,", "respectively.", "<tag3>"], "wordsA": ["We", "expense", "research", "and", "development", "costs", "as", "they", "are", "incurred."], "wordsB": ["We", "will", "recognize", "revenue", "in", "accordance", "with", "FASB", "Accounting", "Standards", "Codification,", "or", "ASC", "605", "Revenue", "Recognition", ",", "subtopic", "ASC", "605-25", "Revenue", "with", "Multiple", "Element", "Arrangements", "and", "subtopic", "ASC", "605-28", "Revenue", "Recognition-Milestone", "Method", ",", "which", "provide", "accounting", "guidance", "for", "revenue", "recognition", "for", "arrangements", "with", "multiple", "deliverables", "and", "guidance", "on", "defining", "the", "milestone", "and", "determining", "when", "the", "use", "of", "the", "milestone", "method", "of", "revenue", "recognition", "for", "research", "and", "development", "transactions", "is", "appropriate,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p38_s0", "idA": "1316175_14_item7_p33_s1", "sentA": "We expense research and development costs as they are incurred.", "sentB": "Revenues under the Zenyaku collaborative agreement will be recognized as research costs are incurred or as the research services are performed over the product development period.", "type": 1, "words": ["<tag1>", "We", "expense", "research", "and", "development", "costs", "as", "they", "are", "incurred.", "<tag2>", "Revenues", "under", "the", "Zenyaku", "collaborative", "agreement", "will", "be", "recognized", "as", "research", "costs", "are", "incurred", "or", "as", "the", "research", "services", "are", "performed", "over", "the", "product", "development", "period.", "<tag3>"], "wordsA": ["We", "expense", "research", "and", "development", "costs", "as", "they", "are", "incurred."], "wordsB": ["Revenues", "under", "the", "Zenyaku", "collaborative", "agreement", "will", "be", "recognized", "as", "research", "costs", "are", "incurred", "or", "as", "the", "research", "services", "are", "performed", "over", "the", "product", "development", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p38_s1", "idA": "1316175_14_item7_p43_s5", "sentA": "If timelines or contracts are modified based upon changes to the clinical study design or scope of work to be performed, we modify our estimates of accrued expenses accordingly on a prospective basis.", "sentB": "The collaborative arrangement is on a best-efforts basis, does not require scientific achievement as a performance obligation and provides for payment to be made when costs are incurred or the services are performed.", "type": 1, "words": ["<tag1>", "If", "timelines", "or", "contracts", "are", "modified", "based", "upon", "changes", "to", "the", "clinical", "study", "design", "or", "scope", "of", "work", "to", "be", "performed,", "we", "modify", "our", "estimates", "of", "accrued", "expenses", "accordingly", "on", "a", "prospective", "basis.", "<tag2>", "The", "collaborative", "arrangement", "is", "on", "a", "best-efforts", "basis,", "does", "not", "require", "scientific", "achievement", "as", "a", "performance", "obligation", "and", "provides", "for", "payment", "to", "be", "made", "when", "costs", "are", "incurred", "or", "the", "services", "are", "performed.", "<tag3>"], "wordsA": ["If", "timelines", "or", "contracts", "are", "modified", "based", "upon", "changes", "to", "the", "clinical", "study", "design", "or", "scope", "of", "work", "to", "be", "performed,", "we", "modify", "our", "estimates", "of", "accrued", "expenses", "accordingly", "on", "a", "prospective", "basis."], "wordsB": ["The", "collaborative", "arrangement", "is", "on", "a", "best-efforts", "basis,", "does", "not", "require", "scientific", "achievement", "as", "a", "performance", "obligation", "and", "provides", "for", "payment", "to", "be", "made", "when", "costs", "are", "incurred", "or", "the", "services", "are", "performed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p15_s3", "idA": "1316175_14_item7_p44_s0", "sentA": "None of our product candidate has received FDA or foreign regulatory marketing approval.", "sentB": "We will periodically review and, if necessary, revise the estimated period of performance of our collaboration.", "type": 1, "words": ["<tag1>", "None", "of", "our", "product", "candidate", "has", "received", "FDA", "or", "foreign", "regulatory", "marketing", "approval.", "<tag2>", "We", "will", "periodically", "review", "and,", "if", "necessary,", "revise", "the", "estimated", "period", "of", "performance", "of", "our", "collaboration.", "<tag3>"], "wordsA": ["None", "of", "our", "product", "candidate", "has", "received", "FDA", "or", "foreign", "regulatory", "marketing", "approval."], "wordsB": ["We", "will", "periodically", "review", "and,", "if", "necessary,", "revise", "the", "estimated", "period", "of", "performance", "of", "our", "collaboration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p35_s0", "idA": "1316175_14_item7_p48_s0", "sentA": "We base our estimates on our historical experience and on various other assumptions that we believe to be reasonable under the circumstances.", "sentB": "The deliverables under the Zenyaku agreement have been determined to be a single unit of accounting and as such the non-refundable, up-front fees will be recorded as deferred revenue and recognized ratably over the term of its estimated performance period under the agreement, which is the product development period.", "type": 1, "words": ["<tag1>", "We", "base", "our", "estimates", "on", "our", "historical", "experience", "and", "on", "various", "other", "assumptions", "that", "we", "believe", "to", "be", "reasonable", "under", "the", "circumstances.", "<tag2>", "The", "deliverables", "under", "the", "Zenyaku", "agreement", "have", "been", "determined", "to", "be", "a", "single", "unit", "of", "accounting", "and", "as", "such", "the", "non-refundable,", "up-front", "fees", "will", "be", "recorded", "as", "deferred", "revenue", "and", "recognized", "ratably", "over", "the", "term", "of", "its", "estimated", "performance", "period", "under", "the", "agreement,", "which", "is", "the", "product", "development", "period.", "<tag3>"], "wordsA": ["We", "base", "our", "estimates", "on", "our", "historical", "experience", "and", "on", "various", "other", "assumptions", "that", "we", "believe", "to", "be", "reasonable", "under", "the", "circumstances."], "wordsB": ["The", "deliverables", "under", "the", "Zenyaku", "agreement", "have", "been", "determined", "to", "be", "a", "single", "unit", "of", "accounting", "and", "as", "such", "the", "non-refundable,", "up-front", "fees", "will", "be", "recorded", "as", "deferred", "revenue", "and", "recognized", "ratably", "over", "the", "term", "of", "its", "estimated", "performance", "period", "under", "the", "agreement,", "which", "is", "the", "product", "development", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p39_s1", "idA": "1316175_14_item7_p51_s1", "sentA": "Inherent in this model are assumptions related to expected stock price volatility, expected life, risk-free interest rate and dividend yield.", "sentB": "Reimbursement related to FTE services is recognized as research services are performed over the related performance periods.", "type": 1, "words": ["<tag1>", "Inherent", "in", "this", "model", "are", "assumptions", "related", "to", "expected", "stock", "price", "volatility,", "expected", "life,", "risk-free", "interest", "rate", "and", "dividend", "yield.", "<tag2>", "Reimbursement", "related", "to", "FTE", "services", "is", "recognized", "as", "research", "services", "are", "performed", "over", "the", "related", "performance", "periods.", "<tag3>"], "wordsA": ["Inherent", "in", "this", "model", "are", "assumptions", "related", "to", "expected", "stock", "price", "volatility,", "expected", "life,", "risk-free", "interest", "rate", "and", "dividend", "yield."], "wordsB": ["Reimbursement", "related", "to", "FTE", "services", "is", "recognized", "as", "research", "services", "are", "performed", "over", "the", "related", "performance", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p9_s2", "idA": "1316175_14_item7_p53_s3", "sentA": "We periodically confirm the accuracy of our estimates with the service providers and make adjustments if necessary.", "sentB": "Rather, the analysis suggests that the observed data conforms with the assumptions upon which the trial was designed.", "type": 1, "words": ["<tag1>", "We", "periodically", "confirm", "the", "accuracy", "of", "our", "estimates", "with", "the", "service", "providers", "and", "make", "adjustments", "if", "necessary.", "<tag2>", "Rather,", "the", "analysis", "suggests", "that", "the", "observed", "data", "conforms", "with", "the", "assumptions", "upon", "which", "the", "trial", "was", "designed.", "<tag3>"], "wordsA": ["We", "periodically", "confirm", "the", "accuracy", "of", "our", "estimates", "with", "the", "service", "providers", "and", "make", "adjustments", "if", "necessary."], "wordsB": ["Rather,", "the", "analysis", "suggests", "that", "the", "observed", "data", "conforms", "with", "the", "assumptions", "upon", "which", "the", "trial", "was", "designed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p13_s5", "idA": "1316175_14_item7_p68_s4", "sentA": "The fluctuation was primarily due to change in the fair value of our common stock and the related impact on the fair value of the warrant liability.", "sentB": "The EMA also recommended the protocol to provide information on the recommended duration of treatment, duration of response and need for re-treatment.", "type": 1, "words": ["<tag1>", "The", "fluctuation", "was", "primarily", "due", "to", "change", "in", "the", "fair", "value", "of", "our", "common", "stock", "and", "the", "related", "impact", "on", "the", "fair", "value", "of", "the", "warrant", "liability.", "<tag2>", "The", "EMA", "also", "recommended", "the", "protocol", "to", "provide", "information", "on", "the", "recommended", "duration", "of", "treatment,", "duration", "of", "response", "and", "need", "for", "re-treatment.", "<tag3>"], "wordsA": ["The", "fluctuation", "was", "primarily", "due", "to", "change", "in", "the", "fair", "value", "of", "our", "common", "stock", "and", "the", "related", "impact", "on", "the", "fair", "value", "of", "the", "warrant", "liability."], "wordsB": ["The", "EMA", "also", "recommended", "the", "protocol", "to", "provide", "information", "on", "the", "recommended", "duration", "of", "treatment,", "duration", "of", "response", "and", "need", "for", "re-treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p10_s2", "idA": "1316175_14_item7_p76_s0", "sentA": "Cash, cash equivalents and investments consist of the following (in thousands):", "sentB": "The available data suggests an improved consistency of the SRI-6 endpoint across multiple trials .", "type": 1, "words": ["<tag1>", "Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "thousands):", "<tag2>", "The", "available", "data", "suggests", "an", "improved", "consistency", "of", "the", "SRI-6", "endpoint", "across", "multiple", "trials", ".", "<tag3>"], "wordsA": ["Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "thousands):"], "wordsB": ["The", "available", "data", "suggests", "an", "improved", "consistency", "of", "the", "SRI-6", "endpoint", "across", "multiple", "trials", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p34_s0", "idA": "1316175_14_item7_p76_s0", "sentA": "Cash, cash equivalents and investments consist of the following (in thousands):", "sentB": "For multiple-element arrangements, each deliverable within a multiple deliverable revenue arrangement is accounted for as a separate unit of accounting if both of the following criteria are met: (1) the delivered item or items have value to the customer on a standalone basis and (2) for an arrangement that includes a general right of return relative to the delivered item(s), delivery or performance of the undelivered item(s) is considered probable and substantially in our control.", "type": 1, "words": ["<tag1>", "Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "thousands):", "<tag2>", "For", "multiple-element", "arrangements,", "each", "deliverable", "within", "a", "multiple", "deliverable", "revenue", "arrangement", "is", "accounted", "for", "as", "a", "separate", "unit", "of", "accounting", "if", "both", "of", "the", "following", "criteria", "are", "met:", "(1)", "the", "delivered", "item", "or", "items", "have", "value", "to", "the", "customer", "on", "a", "standalone", "basis", "and", "(2)", "for", "an", "arrangement", "that", "includes", "a", "general", "right", "of", "return", "relative", "to", "the", "delivered", "item(s),", "delivery", "or", "performance", "of", "the", "undelivered", "item(s)", "is", "considered", "probable", "and", "substantially", "in", "our", "control.", "<tag3>"], "wordsA": ["Cash,", "cash", "equivalents", "and", "investments", "consist", "of", "the", "following", "(in", "thousands):"], "wordsB": ["For", "multiple-element", "arrangements,", "each", "deliverable", "within", "a", "multiple", "deliverable", "revenue", "arrangement", "is", "accounted", "for", "as", "a", "separate", "unit", "of", "accounting", "if", "both", "of", "the", "following", "criteria", "are", "met:", "(1)", "the", "delivered", "item", "or", "items", "have", "value", "to", "the", "customer", "on", "a", "standalone", "basis", "and", "(2)", "for", "an", "arrangement", "that", "includes", "a", "general", "right", "of", "return", "relative", "to", "the", "delivered", "item(s),", "delivery", "or", "performance", "of", "the", "undelivered", "item(s)", "is", "considered", "probable", "and", "substantially", "in", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p67_s1", "idA": "1316175_14_item7_p78_s3", "sentA": "As of December 31, 2013, approximately $15.4 million of shares of our common stock remained available to be sold under the Purchase Agreement.", "sentB": "The Purchase Agreement will expire in April 2015.", "type": 1, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "approximately", "$15.4", "million", "of", "shares", "of", "our", "common", "stock", "remained", "available", "to", "be", "sold", "under", "the", "Purchase", "Agreement.", "<tag2>", "The", "Purchase", "Agreement", "will", "expire", "in", "April", "2015.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "approximately", "$15.4", "million", "of", "shares", "of", "our", "common", "stock", "remained", "available", "to", "be", "sold", "under", "the", "Purchase", "Agreement."], "wordsB": ["The", "Purchase", "Agreement", "will", "expire", "in", "April", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p39_s0", "idA": "1316175_14_item7_p91_s0", "sentA": "We have lease obligations consisting of an operating lease for our operating facility that expires in September 2017.", "sentB": "Additionally, we receive reimbursement for our personnel cost at a pre-determined full time equivalent (FTE) rate.", "type": 1, "words": ["<tag1>", "We", "have", "lease", "obligations", "consisting", "of", "an", "operating", "lease", "for", "our", "operating", "facility", "that", "expires", "in", "September", "2017.", "<tag2>", "Additionally,", "we", "receive", "reimbursement", "for", "our", "personnel", "cost", "at", "a", "pre-determined", "full", "time", "equivalent", "(FTE)", "rate.", "<tag3>"], "wordsA": ["We", "have", "lease", "obligations", "consisting", "of", "an", "operating", "lease", "for", "our", "operating", "facility", "that", "expires", "in", "September", "2017."], "wordsB": ["Additionally,", "we", "receive", "reimbursement", "for", "our", "personnel", "cost", "at", "a", "pre-determined", "full", "time", "equivalent", "(FTE)", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_15_item7_p36_s0", "idA": "1316175_14_item7_p94_s1", "sentA": "Under our license agreement with Amgen to develop and commercialize blisibimod, we are obligated to make additional milestone payments upon the achievement of certain development, regulatory and commercial objectives.", "sentB": "We recognize revenue from milestone payments when: (i) the milestone event is substantive and its achievability has substantive uncertainty at the inception of the agreement, and (ii) we do not have ongoing performance obligations related to the achievement of the milestone earned.", "type": 1, "words": ["<tag1>", "Under", "our", "license", "agreement", "with", "Amgen", "to", "develop", "and", "commercialize", "blisibimod,", "we", "are", "obligated", "to", "make", "additional", "milestone", "payments", "upon", "the", "achievement", "of", "certain", "development,", "regulatory", "and", "commercial", "objectives.", "<tag2>", "We", "recognize", "revenue", "from", "milestone", "payments", "when:", "(i)", "the", "milestone", "event", "is", "substantive", "and", "its", "achievability", "has", "substantive", "uncertainty", "at", "the", "inception", "of", "the", "agreement,", "and", "(ii)", "we", "do", "not", "have", "ongoing", "performance", "obligations", "related", "to", "the", "achievement", "of", "the", "milestone", "earned.", "<tag3>"], "wordsA": ["Under", "our", "license", "agreement", "with", "Amgen", "to", "develop", "and", "commercialize", "blisibimod,", "we", "are", "obligated", "to", "make", "additional", "milestone", "payments", "upon", "the", "achievement", "of", "certain", "development,", "regulatory", "and", "commercial", "objectives."], "wordsB": ["We", "recognize", "revenue", "from", "milestone", "payments", "when:", "(i)", "the", "milestone", "event", "is", "substantive", "and", "its", "achievability", "has", "substantive", "uncertainty", "at", "the", "inception", "of", "the", "agreement,", "and", "(ii)", "we", "do", "not", "have", "ongoing", "performance", "obligations", "related", "to", "the", "achievement", "of", "the", "milestone", "earned."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p16_s0", "idA": "1316175_15_item7_p13_s1", "sentA": "In April 2014, we met with the Japan Pharmaceuticals and Medical Devices Agency ( PMDA ) to discuss our registration program for blisibimod in IgA nephropathy.", "sentB": "We believe the CHABLIS development program for blisibimod may offer a number of potential opportunities for differentiation versus the currently marketed BAFF antagonist and other novel B-cell directed therapies, including:", "type": 1, "words": ["<tag1>", "In", "April", "2014,", "we", "met", "with", "the", "Japan", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(", "PMDA", ")", "to", "discuss", "our", "registration", "program", "for", "blisibimod", "in", "IgA", "nephropathy.", "<tag2>", "We", "believe", "the", "CHABLIS", "development", "program", "for", "blisibimod", "may", "offer", "a", "number", "of", "potential", "opportunities", "for", "differentiation", "versus", "the", "currently", "marketed", "BAFF", "antagonist", "and", "other", "novel", "B-cell", "directed", "therapies,", "including:", "<tag3>"], "wordsA": ["In", "April", "2014,", "we", "met", "with", "the", "Japan", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(", "PMDA", ")", "to", "discuss", "our", "registration", "program", "for", "blisibimod", "in", "IgA", "nephropathy."], "wordsB": ["We", "believe", "the", "CHABLIS", "development", "program", "for", "blisibimod", "may", "offer", "a", "number", "of", "potential", "opportunities", "for", "differentiation", "versus", "the", "currently", "marketed", "BAFF", "antagonist", "and", "other", "novel", "B-cell", "directed", "therapies,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p45_s3", "idA": "1316175_15_item7_p17_s0", "sentA": "Licensing costs consist primarily of fees paid pursuant to license agreements.", "sentB": "The collaboration was terminated on January 7, 2016 pursuant to a termination notice from Zenyaku to us.", "type": 1, "words": ["<tag1>", "Licensing", "costs", "consist", "primarily", "of", "fees", "paid", "pursuant", "to", "license", "agreements.", "<tag2>", "The", "collaboration", "was", "terminated", "on", "January", "7,", "2016", "pursuant", "to", "a", "termination", "notice", "from", "Zenyaku", "to", "us.", "<tag3>"], "wordsA": ["Licensing", "costs", "consist", "primarily", "of", "fees", "paid", "pursuant", "to", "license", "agreements."], "wordsB": ["The", "collaboration", "was", "terminated", "on", "January", "7,", "2016", "pursuant", "to", "a", "termination", "notice", "from", "Zenyaku", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p4_s1", "idA": "1316175_15_item7_p18_s1", "sentA": "We expect to incur substantial clinical development costs for the continued development of blisibimod.", "sentB": "We currently have two compounds in development, liprotamase and blisibimod.", "type": 1, "words": ["<tag1>", "We", "expect", "to", "incur", "substantial", "clinical", "development", "costs", "for", "the", "continued", "development", "of", "blisibimod.", "<tag2>", "We", "currently", "have", "two", "compounds", "in", "development,", "liprotamase", "and", "blisibimod.", "<tag3>"], "wordsA": ["We", "expect", "to", "incur", "substantial", "clinical", "development", "costs", "for", "the", "continued", "development", "of", "blisibimod."], "wordsB": ["We", "currently", "have", "two", "compounds", "in", "development,", "liprotamase", "and", "blisibimod."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p14_s0", "idA": "1316175_15_item7_p21_s0", "sentA": "Included non-cash license fee $1.0 million in connection with an amendment to the Amgen Agreement.", "sentB": "a sachet formulation containing liprotamase power for oral solution which can be easily dissolved into water, and finally provides patients, especially young pediatric patients, with an easy-to-swallow dosing option.", "type": 1, "words": ["<tag1>", "Included", "non-cash", "license", "fee", "$1.0", "million", "in", "connection", "with", "an", "amendment", "to", "the", "Amgen", "Agreement.", "<tag2>", "a", "sachet", "formulation", "containing", "liprotamase", "power", "for", "oral", "solution", "which", "can", "be", "easily", "dissolved", "into", "water,", "and", "finally", "provides", "patients,", "especially", "young", "pediatric", "patients,", "with", "an", "easy-to-swallow", "dosing", "option.", "<tag3>"], "wordsA": ["Included", "non-cash", "license", "fee", "$1.0", "million", "in", "connection", "with", "an", "amendment", "to", "the", "Amgen", "Agreement."], "wordsB": ["a", "sachet", "formulation", "containing", "liprotamase", "power", "for", "oral", "solution", "which", "can", "be", "easily", "dissolved", "into", "water,", "and", "finally", "provides", "patients,", "especially", "young", "pediatric", "patients,", "with", "an", "easy-to-swallow", "dosing", "option."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p21_s1", "idA": "1316175_15_item7_p24_s2", "sentA": "As we obtain results from clinical studies, we may elect to discontinue or delay clinical studies for certain clinical development programs in order to focus our resources on more promising clinical development programs.", "sentB": "The CHABLIS 7.5 study s name emphasizes the intent to reduce background corticosteroid medication to 7.5mg prednisone in order to mitigate the risks associated with long-term steroid medication.", "type": 1, "words": ["<tag1>", "As", "we", "obtain", "results", "from", "clinical", "studies,", "we", "may", "elect", "to", "discontinue", "or", "delay", "clinical", "studies", "for", "certain", "clinical", "development", "programs", "in", "order", "to", "focus", "our", "resources", "on", "more", "promising", "clinical", "development", "programs.", "<tag2>", "The", "CHABLIS", "7.5", "study", "s", "name", "emphasizes", "the", "intent", "to", "reduce", "background", "corticosteroid", "medication", "to", "7.5mg", "prednisone", "in", "order", "to", "mitigate", "the", "risks", "associated", "with", "long-term", "steroid", "medication.", "<tag3>"], "wordsA": ["As", "we", "obtain", "results", "from", "clinical", "studies,", "we", "may", "elect", "to", "discontinue", "or", "delay", "clinical", "studies", "for", "certain", "clinical", "development", "programs", "in", "order", "to", "focus", "our", "resources", "on", "more", "promising", "clinical", "development", "programs."], "wordsB": ["The", "CHABLIS", "7.5", "study", "s", "name", "emphasizes", "the", "intent", "to", "reduce", "background", "corticosteroid", "medication", "to", "7.5mg", "prednisone", "in", "order", "to", "mitigate", "the", "risks", "associated", "with", "long-term", "steroid", "medication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p12_s5", "idA": "1316175_15_item7_p24_s4", "sentA": "The cost of clinical studies may vary significantly over the life of a program as a result of differences arising during clinical development, including:", "sentB": "We believe the SOLUTION and SIMPLICITY studies may offer a number of potential opportunities for differentiation versus the currently marketed PERTs, including:", "type": 1, "words": ["<tag1>", "The", "cost", "of", "clinical", "studies", "may", "vary", "significantly", "over", "the", "life", "of", "a", "program", "as", "a", "result", "of", "differences", "arising", "during", "clinical", "development,", "including:", "<tag2>", "We", "believe", "the", "SOLUTION", "and", "SIMPLICITY", "studies", "may", "offer", "a", "number", "of", "potential", "opportunities", "for", "differentiation", "versus", "the", "currently", "marketed", "PERTs,", "including:", "<tag3>"], "wordsA": ["The", "cost", "of", "clinical", "studies", "may", "vary", "significantly", "over", "the", "life", "of", "a", "program", "as", "a", "result", "of", "differences", "arising", "during", "clinical", "development,", "including:"], "wordsB": ["We", "believe", "the", "SOLUTION", "and", "SIMPLICITY", "studies", "may", "offer", "a", "number", "of", "potential", "opportunities", "for", "differentiation", "versus", "the", "currently", "marketed", "PERTs,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p12_s4", "idA": "1316175_15_item7_p25_s3", "sentA": "Payments under the contracts are mainly driven by time and materials incurred by these service providers.", "sentB": "The SIMPLICITY study will use sachets containing a formulation of liprotamase powder for oral solution for ease of administration, and will enroll approximately 60 patients.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers.", "<tag2>", "The", "SIMPLICITY", "study", "will", "use", "sachets", "containing", "a", "formulation", "of", "liprotamase", "powder", "for", "oral", "solution", "for", "ease", "of", "administration,", "and", "will", "enroll", "approximately", "60", "patients.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers."], "wordsB": ["The", "SIMPLICITY", "study", "will", "use", "sachets", "containing", "a", "formulation", "of", "liprotamase", "powder", "for", "oral", "solution", "for", "ease", "of", "administration,", "and", "will", "enroll", "approximately", "60", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p13_s0", "idA": "1316175_15_item7_p25_s3", "sentA": "Payments under the contracts are mainly driven by time and materials incurred by these service providers.", "sentB": "a capsule formulation using known, safe, excipients that provides lower pill burden and good delivery performance.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers.", "<tag2>", "a", "capsule", "formulation", "using", "known,", "safe,", "excipients", "that", "provides", "lower", "pill", "burden", "and", "good", "delivery", "performance.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers."], "wordsB": ["a", "capsule", "formulation", "using", "known,", "safe,", "excipients", "that", "provides", "lower", "pill", "burden", "and", "good", "delivery", "performance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p18_s1", "idA": "1316175_15_item7_p25_s3", "sentA": "Payments under the contracts are mainly driven by time and materials incurred by these service providers.", "sentB": "During these regular meetings, the DSMB reviews un-blinded safety data which include adverse events, suspected unexpected serious adverse reactions or SUSARs, deaths, laboratory data, and withdrawal data and compares trends between treatments.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers.", "<tag2>", "During", "these", "regular", "meetings,", "the", "DSMB", "reviews", "un-blinded", "safety", "data", "which", "include", "adverse", "events,", "suspected", "unexpected", "serious", "adverse", "reactions", "or", "SUSARs,", "deaths,", "laboratory", "data,", "and", "withdrawal", "data", "and", "compares", "trends", "between", "treatments.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers."], "wordsB": ["During", "these", "regular", "meetings,", "the", "DSMB", "reviews", "un-blinded", "safety", "data", "which", "include", "adverse", "events,", "suspected", "unexpected", "serious", "adverse", "reactions", "or", "SUSARs,", "deaths,", "laboratory", "data,", "and", "withdrawal", "data", "and", "compares", "trends", "between", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p45_s1", "idA": "1316175_15_item7_p25_s3", "sentA": "Payments under the contracts are mainly driven by time and materials incurred by these service providers.", "sentB": "All payments from Zenyaku were nonrefundable.", "type": 1, "words": ["<tag1>", "Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers.", "<tag2>", "All", "payments", "from", "Zenyaku", "were", "nonrefundable.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "are", "mainly", "driven", "by", "time", "and", "materials", "incurred", "by", "these", "service", "providers."], "wordsB": ["All", "payments", "from", "Zenyaku", "were", "nonrefundable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p9_s1", "idA": "1316175_15_item7_p35_s0", "sentA": "The deliverables under the Zenyaku agreement have been determined to be a single unit of accounting and as such the non-refundable, up-front fees will be recorded as deferred revenue and recognized ratably over the term of its estimated performance period under the agreement, which is the product development period.", "sentB": "In September 2015, Zenyaku provided us a notice of its intent to terminate the Zenyaku Agreement, effective January 7, 2016.", "type": 1, "words": ["<tag1>", "The", "deliverables", "under", "the", "Zenyaku", "agreement", "have", "been", "determined", "to", "be", "a", "single", "unit", "of", "accounting", "and", "as", "such", "the", "non-refundable,", "up-front", "fees", "will", "be", "recorded", "as", "deferred", "revenue", "and", "recognized", "ratably", "over", "the", "term", "of", "its", "estimated", "performance", "period", "under", "the", "agreement,", "which", "is", "the", "product", "development", "period.", "<tag2>", "In", "September", "2015,", "Zenyaku", "provided", "us", "a", "notice", "of", "its", "intent", "to", "terminate", "the", "Zenyaku", "Agreement,", "effective", "January", "7,", "2016.", "<tag3>"], "wordsA": ["The", "deliverables", "under", "the", "Zenyaku", "agreement", "have", "been", "determined", "to", "be", "a", "single", "unit", "of", "accounting", "and", "as", "such", "the", "non-refundable,", "up-front", "fees", "will", "be", "recorded", "as", "deferred", "revenue", "and", "recognized", "ratably", "over", "the", "term", "of", "its", "estimated", "performance", "period", "under", "the", "agreement,", "which", "is", "the", "product", "development", "period."], "wordsB": ["In", "September", "2015,", "Zenyaku", "provided", "us", "a", "notice", "of", "its", "intent", "to", "terminate", "the", "Zenyaku", "Agreement,", "effective", "January", "7,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p65_s2", "idA": "1316175_15_item7_p39_s1", "sentA": "Reimbursement related to FTE services is recognized as research services are performed over the related performance periods.", "sentB": "The amount has been recognized as a component of Operating Expenses.", "type": 1, "words": ["<tag1>", "Reimbursement", "related", "to", "FTE", "services", "is", "recognized", "as", "research", "services", "are", "performed", "over", "the", "related", "performance", "periods.", "<tag2>", "The", "amount", "has", "been", "recognized", "as", "a", "component", "of", "Operating", "Expenses.", "<tag3>"], "wordsA": ["Reimbursement", "related", "to", "FTE", "services", "is", "recognized", "as", "research", "services", "are", "performed", "over", "the", "related", "performance", "periods."], "wordsB": ["The", "amount", "has", "been", "recognized", "as", "a", "component", "of", "Operating", "Expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p17_s0", "idA": "1316175_15_item7_p59_s0", "sentA": "During the year ended December 31, 2013, our research and development costs consisted primarily of start-up clinical expenses for the Phase 3 CHABLIS-SC1 and Phase 2 BRIGHT-SC1 studies and the ongoing costs to support the PEARL-SC OLE study.", "sentB": "fully human IgG1 Fc domain confers acceptable pharmacokinetic properties to support once-weekly dosing.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2013,", "our", "research", "and", "development", "costs", "consisted", "primarily", "of", "start-up", "clinical", "expenses", "for", "the", "Phase", "3", "CHABLIS-SC1", "and", "Phase", "2", "BRIGHT-SC1", "studies", "and", "the", "ongoing", "costs", "to", "support", "the", "PEARL-SC", "OLE", "study.", "<tag2>", "fully", "human", "IgG1", "Fc", "domain", "confers", "acceptable", "pharmacokinetic", "properties", "to", "support", "once-weekly", "dosing.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2013,", "our", "research", "and", "development", "costs", "consisted", "primarily", "of", "start-up", "clinical", "expenses", "for", "the", "Phase", "3", "CHABLIS-SC1", "and", "Phase", "2", "BRIGHT-SC1", "studies", "and", "the", "ongoing", "costs", "to", "support", "the", "PEARL-SC", "OLE", "study."], "wordsB": ["fully", "human", "IgG1", "Fc", "domain", "confers", "acceptable", "pharmacokinetic", "properties", "to", "support", "once-weekly", "dosing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p4_s2", "idA": "1316175_15_item7_p64_s1", "sentA": "The warrants were reclassified from liabilities into equity in July 2012.", "sentB": "We licensed liprotamase from Eli Lilly Co ( Eli Lilly ) in July 2014 .", "type": 1, "words": ["<tag1>", "The", "warrants", "were", "reclassified", "from", "liabilities", "into", "equity", "in", "July", "2012.", "<tag2>", "We", "licensed", "liprotamase", "from", "Eli", "Lilly", "Co", "(", "Eli", "Lilly", ")", "in", "July", "2014", ".", "<tag3>"], "wordsA": ["The", "warrants", "were", "reclassified", "from", "liabilities", "into", "equity", "in", "July", "2012."], "wordsB": ["We", "licensed", "liprotamase", "from", "Eli", "Lilly", "Co", "(", "Eli", "Lilly", ")", "in", "July", "2014", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p65_s3", "idA": "1316175_15_item7_p64_s2", "sentA": "Therefore, there was no mark-to-market adjustment on warrant liability recorded in the year ended 2013.", "sentB": "There was no research award recognized in 2014.", "type": 1, "words": ["<tag1>", "Therefore,", "there", "was", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "year", "ended", "2013.", "<tag2>", "There", "was", "no", "research", "award", "recognized", "in", "2014.", "<tag3>"], "wordsA": ["Therefore,", "there", "was", "no", "mark-to-market", "adjustment", "on", "warrant", "liability", "recorded", "in", "the", "year", "ended", "2013."], "wordsB": ["There", "was", "no", "research", "award", "recognized", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p28_s3", "idA": "1316175_15_item7_p89_s0", "sentA": "On January 27, 2015, we received $7.0 million from its collaborative partner, Zenyaku, pursuant to the issuance of 2,795,895 shares of our common stock to Zenyaku under the terms of a collaborative arrangement.", "sentB": "In September 2015, we received a termination notice from Zenyaku to terminate the collaborative arrangement, effective January 7, 2016.", "type": 1, "words": ["<tag1>", "On", "January", "27,", "2015,", "we", "received", "$7.0", "million", "from", "its", "collaborative", "partner,", "Zenyaku,", "pursuant", "to", "the", "issuance", "of", "2,795,895", "shares", "of", "our", "common", "stock", "to", "Zenyaku", "under", "the", "terms", "of", "a", "collaborative", "arrangement.", "<tag2>", "In", "September", "2015,", "we", "received", "a", "termination", "notice", "from", "Zenyaku", "to", "terminate", "the", "collaborative", "arrangement,", "effective", "January", "7,", "2016.", "<tag3>"], "wordsA": ["On", "January", "27,", "2015,", "we", "received", "$7.0", "million", "from", "its", "collaborative", "partner,", "Zenyaku,", "pursuant", "to", "the", "issuance", "of", "2,795,895", "shares", "of", "our", "common", "stock", "to", "Zenyaku", "under", "the", "terms", "of", "a", "collaborative", "arrangement."], "wordsB": ["In", "September", "2015,", "we", "received", "a", "termination", "notice", "from", "Zenyaku", "to", "terminate", "the", "collaborative", "arrangement,", "effective", "January", "7,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p59_s3", "idA": "1316175_15_item7_p89_s0", "sentA": "On January 27, 2015, we received $7.0 million from its collaborative partner, Zenyaku, pursuant to the issuance of 2,795,895 shares of our common stock to Zenyaku under the terms of a collaborative arrangement.", "sentB": "In September 2015, we received a termination notice from Zenyaku to terminate the collaborative arrangement, effective January 7, 2016.", "type": 1, "words": ["<tag1>", "On", "January", "27,", "2015,", "we", "received", "$7.0", "million", "from", "its", "collaborative", "partner,", "Zenyaku,", "pursuant", "to", "the", "issuance", "of", "2,795,895", "shares", "of", "our", "common", "stock", "to", "Zenyaku", "under", "the", "terms", "of", "a", "collaborative", "arrangement.", "<tag2>", "In", "September", "2015,", "we", "received", "a", "termination", "notice", "from", "Zenyaku", "to", "terminate", "the", "collaborative", "arrangement,", "effective", "January", "7,", "2016.", "<tag3>"], "wordsA": ["On", "January", "27,", "2015,", "we", "received", "$7.0", "million", "from", "its", "collaborative", "partner,", "Zenyaku,", "pursuant", "to", "the", "issuance", "of", "2,795,895", "shares", "of", "our", "common", "stock", "to", "Zenyaku", "under", "the", "terms", "of", "a", "collaborative", "arrangement."], "wordsB": ["In", "September", "2015,", "we", "received", "a", "termination", "notice", "from", "Zenyaku", "to", "terminate", "the", "collaborative", "arrangement,", "effective", "January", "7,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p6_s0", "idA": "1316175_15_item7_p8_s5", "sentA": "Key secondary outcomes from the study, including SRI-8, reduction in the number of lupus flares and steroid use, are intended to further differentiate blisibimod from currently available therapies.", "sentB": "We licensed blisibimod from Amgen, Inc. ( Amgen ) in December 2007.", "type": 1, "words": ["<tag1>", "Key", "secondary", "outcomes", "from", "the", "study,", "including", "SRI-8,", "reduction", "in", "the", "number", "of", "lupus", "flares", "and", "steroid", "use,", "are", "intended", "to", "further", "differentiate", "blisibimod", "from", "currently", "available", "therapies.", "<tag2>", "We", "licensed", "blisibimod", "from", "Amgen,", "Inc.", "(", "Amgen", ")", "in", "December", "2007.", "<tag3>"], "wordsA": ["Key", "secondary", "outcomes", "from", "the", "study,", "including", "SRI-8,", "reduction", "in", "the", "number", "of", "lupus", "flares", "and", "steroid", "use,", "are", "intended", "to", "further", "differentiate", "blisibimod", "from", "currently", "available", "therapies."], "wordsB": ["We", "licensed", "blisibimod", "from", "Amgen,", "Inc.", "(", "Amgen", ")", "in", "December", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_16_item7_p11_s0", "idA": "1316175_15_item7_p91_s3", "sentA": "To the extent our capital resources are insufficient to meet our future capital requirements, we will need to finance our future cash needs through public or private equity offerings, collaboration agreements, debt financings or licensing arrangements.", "sentB": "To the extent CFFT provides or makes available any information, expertise, know-how or other intellectual property related to cystic fibrosis or the treatment, prevention or cure thereof ( CFFT Know-How ) to us, CFFT grants to us a non-exclusive, transferrable, sublicensable, worldwide rights and license under all of CFFT s rights in such CFFT Know-How to assist us to research, develop, commercialize, make or have made, use, sell, have sold, offer for sale, import, export and otherwise exploit the product.", "type": 1, "words": ["<tag1>", "To", "the", "extent", "our", "capital", "resources", "are", "insufficient", "to", "meet", "our", "future", "capital", "requirements,", "we", "will", "need", "to", "finance", "our", "future", "cash", "needs", "through", "public", "or", "private", "equity", "offerings,", "collaboration", "agreements,", "debt", "financings", "or", "licensing", "arrangements.", "<tag2>", "To", "the", "extent", "CFFT", "provides", "or", "makes", "available", "any", "information,", "expertise,", "know-how", "or", "other", "intellectual", "property", "related", "to", "cystic", "fibrosis", "or", "the", "treatment,", "prevention", "or", "cure", "thereof", "(", "CFFT", "Know-How", ")", "to", "us,", "CFFT", "grants", "to", "us", "a", "non-exclusive,", "transferrable,", "sublicensable,", "worldwide", "rights", "and", "license", "under", "all", "of", "CFFT", "s", "rights", "in", "such", "CFFT", "Know-How", "to", "assist", "us", "to", "research,", "develop,", "commercialize,", "make", "or", "have", "made,", "use,", "sell,", "have", "sold,", "offer", "for", "sale,", "import,", "export", "and", "otherwise", "exploit", "the", "product.", "<tag3>"], "wordsA": ["To", "the", "extent", "our", "capital", "resources", "are", "insufficient", "to", "meet", "our", "future", "capital", "requirements,", "we", "will", "need", "to", "finance", "our", "future", "cash", "needs", "through", "public", "or", "private", "equity", "offerings,", "collaboration", "agreements,", "debt", "financings", "or", "licensing", "arrangements."], "wordsB": ["To", "the", "extent", "CFFT", "provides", "or", "makes", "available", "any", "information,", "expertise,", "know-how", "or", "other", "intellectual", "property", "related", "to", "cystic", "fibrosis", "or", "the", "treatment,", "prevention", "or", "cure", "thereof", "(", "CFFT", "Know-How", ")", "to", "us,", "CFFT", "grants", "to", "us", "a", "non-exclusive,", "transferrable,", "sublicensable,", "worldwide", "rights", "and", "license", "under", "all", "of", "CFFT", "s", "rights", "in", "such", "CFFT", "Know-How", "to", "assist", "us", "to", "research,", "develop,", "commercialize,", "make", "or", "have", "made,", "use,", "sell,", "have", "sold,", "offer", "for", "sale,", "import,", "export", "and", "otherwise", "exploit", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p92_s4", "idA": "1316175_16_item7_p101_s1", "sentA": "In addition, we do not engage in trading activities involving non-exchange traded contracts.", "sentB": "Other than those facilities, we currently do not have arrangements to obtain additional financing.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "do", "not", "engage", "in", "trading", "activities", "involving", "non-exchange", "traded", "contracts.", "<tag2>", "Other", "than", "those", "facilities,", "we", "currently", "do", "not", "have", "arrangements", "to", "obtain", "additional", "financing.", "<tag3>"], "wordsA": ["In", "addition,", "we", "do", "not", "engage", "in", "trading", "activities", "involving", "non-exchange", "traded", "contracts."], "wordsB": ["Other", "than", "those", "facilities,", "we", "currently", "do", "not", "have", "arrangements", "to", "obtain", "additional", "financing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p14_s3", "idA": "1316175_16_item7_p12_s2", "sentA": "This pivotal study is intended to evaluate the non-inferiority of liprotamase compared with another commercially available PERT in a population enriched for PERT responders and will enroll approximately 130 patients in the United States and Europe.", "sentB": "We believe that efficacy in the SOLUTION trial was limited by a restrictive dose optimization paradigm in a population whose dose of lipase at baseline had been optimized for porcine PERTs (but not Sollpura) and that modification of the dosing paradigm may allow for success in the RESULT study.", "type": 1, "words": ["<tag1>", "This", "pivotal", "study", "is", "intended", "to", "evaluate", "the", "non-inferiority", "of", "liprotamase", "compared", "with", "another", "commercially", "available", "PERT", "in", "a", "population", "enriched", "for", "PERT", "responders", "and", "will", "enroll", "approximately", "130", "patients", "in", "the", "United", "States", "and", "Europe.", "<tag2>", "We", "believe", "that", "efficacy", "in", "the", "SOLUTION", "trial", "was", "limited", "by", "a", "restrictive", "dose", "optimization", "paradigm", "in", "a", "population", "whose", "dose", "of", "lipase", "at", "baseline", "had", "been", "optimized", "for", "porcine", "PERTs", "(but", "not", "Sollpura)", "and", "that", "modification", "of", "the", "dosing", "paradigm", "may", "allow", "for", "success", "in", "the", "RESULT", "study.", "<tag3>"], "wordsA": ["This", "pivotal", "study", "is", "intended", "to", "evaluate", "the", "non-inferiority", "of", "liprotamase", "compared", "with", "another", "commercially", "available", "PERT", "in", "a", "population", "enriched", "for", "PERT", "responders", "and", "will", "enroll", "approximately", "130", "patients", "in", "the", "United", "States", "and", "Europe."], "wordsB": ["We", "believe", "that", "efficacy", "in", "the", "SOLUTION", "trial", "was", "limited", "by", "a", "restrictive", "dose", "optimization", "paradigm", "in", "a", "population", "whose", "dose", "of", "lipase", "at", "baseline", "had", "been", "optimized", "for", "porcine", "PERTs", "(but", "not", "Sollpura)", "and", "that", "modification", "of", "the", "dosing", "paradigm", "may", "allow", "for", "success", "in", "the", "RESULT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p16_s0", "idA": "1316175_16_item7_p12_s2", "sentA": "This pivotal study is intended to evaluate the non-inferiority of liprotamase compared with another commercially available PERT in a population enriched for PERT responders and will enroll approximately 130 patients in the United States and Europe.", "sentB": "plan to enroll approximately 46 patients in two parts (Part A and Part B).", "type": 1, "words": ["<tag1>", "This", "pivotal", "study", "is", "intended", "to", "evaluate", "the", "non-inferiority", "of", "liprotamase", "compared", "with", "another", "commercially", "available", "PERT", "in", "a", "population", "enriched", "for", "PERT", "responders", "and", "will", "enroll", "approximately", "130", "patients", "in", "the", "United", "States", "and", "Europe.", "<tag2>", "plan", "to", "enroll", "approximately", "46", "patients", "in", "two", "parts", "(Part", "A", "and", "Part", "B).", "<tag3>"], "wordsA": ["This", "pivotal", "study", "is", "intended", "to", "evaluate", "the", "non-inferiority", "of", "liprotamase", "compared", "with", "another", "commercially", "available", "PERT", "in", "a", "population", "enriched", "for", "PERT", "responders", "and", "will", "enroll", "approximately", "130", "patients", "in", "the", "United", "States", "and", "Europe."], "wordsB": ["plan", "to", "enroll", "approximately", "46", "patients", "in", "two", "parts", "(Part", "A", "and", "Part", "B)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p28_s1", "idA": "1316175_16_item7_p15_s4", "sentA": "The primary endpoint of the CHABLIS-SC1 will be clinical improvement in the SRI-6 response at 52 weeks.", "sentB": "As with the analysis in June, the numerical reduction in proteinuria in blisibimod versus placebo treated patients at week 48 did not meet the predefined statistical primary endpoint of complete or partial response.", "type": 1, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "CHABLIS-SC1", "will", "be", "clinical", "improvement", "in", "the", "SRI-6", "response", "at", "52", "weeks.", "<tag2>", "As", "with", "the", "analysis", "in", "June,", "the", "numerical", "reduction", "in", "proteinuria", "in", "blisibimod", "versus", "placebo", "treated", "patients", "at", "week", "48", "did", "not", "meet", "the", "predefined", "statistical", "primary", "endpoint", "of", "complete", "or", "partial", "response.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "CHABLIS-SC1", "will", "be", "clinical", "improvement", "in", "the", "SRI-6", "response", "at", "52", "weeks."], "wordsB": ["As", "with", "the", "analysis", "in", "June,", "the", "numerical", "reduction", "in", "proteinuria", "in", "blisibimod", "versus", "placebo", "treated", "patients", "at", "week", "48", "did", "not", "meet", "the", "predefined", "statistical", "primary", "endpoint", "of", "complete", "or", "partial", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p12_s3", "idA": "1316175_16_item7_p20_s2", "sentA": "Response rates to the SRI-8 responder index will remain a key secondary endpoint of the study.", "sentB": "Topline data announced in December 2016 showed that the study narrowly missed the CFA non-inferiority margin of the primary modified Intent to Treat (mITT) analysis by one percent; however, by additional pre-specified analyses of CFA (mITT-Baseline Observation Carried Forward and Per Protocol), Sollpura met the non-inferiority criterion.", "type": 1, "words": ["<tag1>", "Response", "rates", "to", "the", "SRI-8", "responder", "index", "will", "remain", "a", "key", "secondary", "endpoint", "of", "the", "study.", "<tag2>", "Topline", "data", "announced", "in", "December", "2016", "showed", "that", "the", "study", "narrowly", "missed", "the", "CFA", "non-inferiority", "margin", "of", "the", "primary", "modified", "Intent", "to", "Treat", "(mITT)", "analysis", "by", "one", "percent;", "however,", "by", "additional", "pre-specified", "analyses", "of", "CFA", "(mITT-Baseline", "Observation", "Carried", "Forward", "and", "Per", "Protocol),", "Sollpura", "met", "the", "non-inferiority", "criterion.", "<tag3>"], "wordsA": ["Response", "rates", "to", "the", "SRI-8", "responder", "index", "will", "remain", "a", "key", "secondary", "endpoint", "of", "the", "study."], "wordsB": ["Topline", "data", "announced", "in", "December", "2016", "showed", "that", "the", "study", "narrowly", "missed", "the", "CFA", "non-inferiority", "margin", "of", "the", "primary", "modified", "Intent", "to", "Treat", "(mITT)", "analysis", "by", "one", "percent;", "however,", "by", "additional", "pre-specified", "analyses", "of", "CFA", "(mITT-Baseline", "Observation", "Carried", "Forward", "and", "Per", "Protocol),", "Sollpura", "met", "the", "non-inferiority", "criterion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p19_s0", "idA": "1316175_16_item7_p21_s2", "sentA": "This study will evaluate the effect of blisibimod on top of standard-of-care medication in patients with severe, seropositive SLE that is inadequately controlled with corticosteroids.", "sentB": "A product that is wholly non-porcine.", "type": 1, "words": ["<tag1>", "This", "study", "will", "evaluate", "the", "effect", "of", "blisibimod", "on", "top", "of", "standard-of-care", "medication", "in", "patients", "with", "severe,", "seropositive", "SLE", "that", "is", "inadequately", "controlled", "with", "corticosteroids.", "<tag2>", "A", "product", "that", "is", "wholly", "non-porcine.", "<tag3>"], "wordsA": ["This", "study", "will", "evaluate", "the", "effect", "of", "blisibimod", "on", "top", "of", "standard-of-care", "medication", "in", "patients", "with", "severe,", "seropositive", "SLE", "that", "is", "inadequately", "controlled", "with", "corticosteroids."], "wordsB": ["A", "product", "that", "is", "wholly", "non-porcine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p17_s1", "idA": "1316175_16_item7_p21_s4", "sentA": "We plan to initiate the CHABLIS 7.5 study in the first half of 2016.", "sentB": "We plan to modif y this study to allow patients completing future studies (e.g., RESULT or SIMPLICITY Part B) to have continued access until the BLA for Sollpura is approved by the FDA.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "initiate", "the", "CHABLIS", "7.5", "study", "in", "the", "first", "half", "of", "2016.", "<tag2>", "We", "plan", "to", "modif", "y", "this", "study", "to", "allow", "patients", "completing", "future", "studies", "(e.g.,", "RESULT", "or", "SIMPLICITY", "Part", "B)", "to", "have", "continued", "access", "until", "the", "BLA", "for", "Sollpura", "is", "approved", "by", "the", "FDA.", "<tag3>"], "wordsA": ["We", "plan", "to", "initiate", "the", "CHABLIS", "7.5", "study", "in", "the", "first", "half", "of", "2016."], "wordsB": ["We", "plan", "to", "modif", "y", "this", "study", "to", "allow", "patients", "completing", "future", "studies", "(e.g.,", "RESULT", "or", "SIMPLICITY", "Part", "B)", "to", "have", "continued", "access", "until", "the", "BLA", "for", "Sollpura", "is", "approved", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p38_s0", "idA": "1316175_16_item7_p28_s4", "sentA": "Consequently, we revised the amortization period of our deferred revenue to correspond with the shortened collaboration period and have fully amortized our deferred revenue as of January 7, 2016.", "sentB": "All development efforts for Varespladib were terminated in 2012.", "type": 1, "words": ["<tag1>", "Consequently,", "we", "revised", "the", "amortization", "period", "of", "our", "deferred", "revenue", "to", "correspond", "with", "the", "shortened", "collaboration", "period", "and", "have", "fully", "amortized", "our", "deferred", "revenue", "as", "of", "January", "7,", "2016.", "<tag2>", "All", "development", "efforts", "for", "Varespladib", "were", "terminated", "in", "2012.", "<tag3>"], "wordsA": ["Consequently,", "we", "revised", "the", "amortization", "period", "of", "our", "deferred", "revenue", "to", "correspond", "with", "the", "shortened", "collaboration", "period", "and", "have", "fully", "amortized", "our", "deferred", "revenue", "as", "of", "January", "7,", "2016."], "wordsB": ["All", "development", "efforts", "for", "Varespladib", "were", "terminated", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p58_s0", "idA": "1316175_16_item7_p36_s1", "sentA": "We intend to fund our clinical studies with existing cash and proceeds from potential future debt and equity offerings.", "sentB": "The Company has issued certain financial instruments, including warrants to purchase common stock, which have the characteristics of both liability and equity.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "fund", "our", "clinical", "studies", "with", "existing", "cash", "and", "proceeds", "from", "potential", "future", "debt", "and", "equity", "offerings.", "<tag2>", "The", "Company", "has", "issued", "certain", "financial", "instruments,", "including", "warrants", "to", "purchase", "common", "stock,", "which", "have", "the", "characteristics", "of", "both", "liability", "and", "equity.", "<tag3>"], "wordsA": ["We", "intend", "to", "fund", "our", "clinical", "studies", "with", "existing", "cash", "and", "proceeds", "from", "potential", "future", "debt", "and", "equity", "offerings."], "wordsB": ["The", "Company", "has", "issued", "certain", "financial", "instruments,", "including", "warrants", "to", "purchase", "common", "stock,", "which", "have", "the", "characteristics", "of", "both", "liability", "and", "equity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p112_s3", "idA": "1316175_16_item7_p37_s1", "sentA": "These expenditures are subject to numerous uncertainties in timing and cost to completion.", "sentB": "The financing transaction is expected to close on March 17, 2017, subject to satisfaction of customary closing conditions.", "type": 1, "words": ["<tag1>", "These", "expenditures", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion.", "<tag2>", "The", "financing", "transaction", "is", "expected", "to", "close", "on", "March", "17,", "2017,", "subject", "to", "satisfaction", "of", "customary", "closing", "conditions.", "<tag3>"], "wordsA": ["These", "expenditures", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion."], "wordsB": ["The", "financing", "transaction", "is", "expected", "to", "close", "on", "March", "17,", "2017,", "subject", "to", "satisfaction", "of", "customary", "closing", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p91_s3", "idA": "1316175_16_item7_p37_s1", "sentA": "These expenditures are subject to numerous uncertainties in timing and cost to completion.", "sentB": "The financing transaction is expected to close on March 17, 2017, subject to satisfaction of customary closing conditions.", "type": 1, "words": ["<tag1>", "These", "expenditures", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion.", "<tag2>", "The", "financing", "transaction", "is", "expected", "to", "close", "on", "March", "17,", "2017,", "subject", "to", "satisfaction", "of", "customary", "closing", "conditions.", "<tag3>"], "wordsA": ["These", "expenditures", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion."], "wordsB": ["The", "financing", "transaction", "is", "expected", "to", "close", "on", "March", "17,", "2017,", "subject", "to", "satisfaction", "of", "customary", "closing", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p12_s5", "idA": "1316175_16_item7_p39_s0", "sentA": "None of our product candidates has received FDA or foreign regulatory marketing approval.", "sentB": "CNA is a measure of protein digestion and absorption and is a key requirement of our planned US FDA regulatory submission.", "type": 1, "words": ["<tag1>", "None", "of", "our", "product", "candidates", "has", "received", "FDA", "or", "foreign", "regulatory", "marketing", "approval.", "<tag2>", "CNA", "is", "a", "measure", "of", "protein", "digestion", "and", "absorption", "and", "is", "a", "key", "requirement", "of", "our", "planned", "US", "FDA", "regulatory", "submission.", "<tag3>"], "wordsA": ["None", "of", "our", "product", "candidates", "has", "received", "FDA", "or", "foreign", "regulatory", "marketing", "approval."], "wordsB": ["CNA", "is", "a", "measure", "of", "protein", "digestion", "and", "absorption", "and", "is", "a", "key", "requirement", "of", "our", "planned", "US", "FDA", "regulatory", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p86_s1", "idA": "1316175_16_item7_p76_s3", "sentA": "The Purchase Agreement will expire in March 2017.", "sentB": "No further investments were made by the investors and the right for Additional Investment expired on January 26, 2017.", "type": 1, "words": ["<tag1>", "The", "Purchase", "Agreement", "will", "expire", "in", "March", "2017.", "<tag2>", "No", "further", "investments", "were", "made", "by", "the", "investors", "and", "the", "right", "for", "Additional", "Investment", "expired", "on", "January", "26,", "2017.", "<tag3>"], "wordsA": ["The", "Purchase", "Agreement", "will", "expire", "in", "March", "2017."], "wordsB": ["No", "further", "investments", "were", "made", "by", "the", "investors", "and", "the", "right", "for", "Additional", "Investment", "expired", "on", "January", "26,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p85_s0", "idA": "1316175_16_item7_p77_s0", "sentA": "On November 15, 2013, we entered into a Sales Agreement (the Agreement ) with Cowen to create an at-the-market ( ATM ) offering program under which the Company from time to time may offer and sell shares of its common stock, par value $0.001 per share, having an aggregate offering price of up to $25.0 million through Cowen, as agent.", "sentB": "In September 2016, we entered into a subscription agreement with certain institutional investors, pursuant to which we sold 17,000 Series X units for a purchase price of $1,000 per unit in a registered direct offering.", "type": 1, "words": ["<tag1>", "On", "November", "15,", "2013,", "we", "entered", "into", "a", "Sales", "Agreement", "(the", "Agreement", ")", "with", "Cowen", "to", "create", "an", "at-the-market", "(", "ATM", ")", "offering", "program", "under", "which", "the", "Company", "from", "time", "to", "time", "may", "offer", "and", "sell", "shares", "of", "its", "common", "stock,", "par", "value", "$0.001", "per", "share,", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million", "through", "Cowen,", "as", "agent.", "<tag2>", "In", "September", "2016,", "we", "entered", "into", "a", "subscription", "agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "we", "sold", "17,000", "Series", "X", "units", "for", "a", "purchase", "price", "of", "$1,000", "per", "unit", "in", "a", "registered", "direct", "offering.", "<tag3>"], "wordsA": ["On", "November", "15,", "2013,", "we", "entered", "into", "a", "Sales", "Agreement", "(the", "Agreement", ")", "with", "Cowen", "to", "create", "an", "at-the-market", "(", "ATM", ")", "offering", "program", "under", "which", "the", "Company", "from", "time", "to", "time", "may", "offer", "and", "sell", "shares", "of", "its", "common", "stock,", "par", "value", "$0.001", "per", "share,", "having", "an", "aggregate", "offering", "price", "of", "up", "to", "$25.0", "million", "through", "Cowen,", "as", "agent."], "wordsB": ["In", "September", "2016,", "we", "entered", "into", "a", "subscription", "agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "we", "sold", "17,000", "Series", "X", "units", "for", "a", "purchase", "price", "of", "$1,000", "per", "unit", "in", "a", "registered", "direct", "offering."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p85_s1", "idA": "1316175_16_item7_p78_s4", "sentA": "In March and July 2015, we utilized $57.5 million of this registration statement through the issuance of 10,222,223 shares of common stock in two separate public offerings.", "sentB": "Each unit consists of one share of Series X Convertible Preferred Stock and a warrant to purchase 126.96 shares of common stock at an exercise price of $2.36 per share, which is a 20% premium over the conversion price of Series X Convertible Preferred Stock.", "type": 1, "words": ["<tag1>", "In", "March", "and", "July", "2015,", "we", "utilized", "$57.5", "million", "of", "this", "registration", "statement", "through", "the", "issuance", "of", "10,222,223", "shares", "of", "common", "stock", "in", "two", "separate", "public", "offerings.", "<tag2>", "Each", "unit", "consists", "of", "one", "share", "of", "Series", "X", "Convertible", "Preferred", "Stock", "and", "a", "warrant", "to", "purchase", "126.96", "shares", "of", "common", "stock", "at", "an", "exercise", "price", "of", "$2.36", "per", "share,", "which", "is", "a", "20%", "premium", "over", "the", "conversion", "price", "of", "Series", "X", "Convertible", "Preferred", "Stock.", "<tag3>"], "wordsA": ["In", "March", "and", "July", "2015,", "we", "utilized", "$57.5", "million", "of", "this", "registration", "statement", "through", "the", "issuance", "of", "10,222,223", "shares", "of", "common", "stock", "in", "two", "separate", "public", "offerings."], "wordsB": ["Each", "unit", "consists", "of", "one", "share", "of", "Series", "X", "Convertible", "Preferred", "Stock", "and", "a", "warrant", "to", "purchase", "126.96", "shares", "of", "common", "stock", "at", "an", "exercise", "price", "of", "$2.36", "per", "share,", "which", "is", "a", "20%", "premium", "over", "the", "conversion", "price", "of", "Series", "X", "Convertible", "Preferred", "Stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p92_s2", "idA": "1316175_16_item7_p87_s0", "sentA": "During the year ended December 31, 2014, financing activities used cash of $7.7 million, which represented the net effect of $18.1 million used for the early retirement of our debt to MidCap, offset by $10.4 million in net proceeds received from the sale of stock to LPC and pursuant to the ATM.", "sentB": "Despite the capacity remaining under our registration statement and the remaining amounts available under our ATM and LPC Purchase Agreement, pursuant to Instruction I.B.6 to Form S-3, we may not sell more than the equivalent of one-third of our public float during any 12 consecutive months so long as our public float is less than $75 million, which will limit our ability to raise funds using those facilities.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2014,", "financing", "activities", "used", "cash", "of", "$7.7", "million,", "which", "represented", "the", "net", "effect", "of", "$18.1", "million", "used", "for", "the", "early", "retirement", "of", "our", "debt", "to", "MidCap,", "offset", "by", "$10.4", "million", "in", "net", "proceeds", "received", "from", "the", "sale", "of", "stock", "to", "LPC", "and", "pursuant", "to", "the", "ATM.", "<tag2>", "Despite", "the", "capacity", "remaining", "under", "our", "registration", "statement", "and", "the", "remaining", "amounts", "available", "under", "our", "ATM", "and", "LPC", "Purchase", "Agreement,", "pursuant", "to", "Instruction", "I.B.6", "to", "Form", "S-3,", "we", "may", "not", "sell", "more", "than", "the", "equivalent", "of", "one-third", "of", "our", "public", "float", "during", "any", "12", "consecutive", "months", "so", "long", "as", "our", "public", "float", "is", "less", "than", "$75", "million,", "which", "will", "limit", "our", "ability", "to", "raise", "funds", "using", "those", "facilities.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2014,", "financing", "activities", "used", "cash", "of", "$7.7", "million,", "which", "represented", "the", "net", "effect", "of", "$18.1", "million", "used", "for", "the", "early", "retirement", "of", "our", "debt", "to", "MidCap,", "offset", "by", "$10.4", "million", "in", "net", "proceeds", "received", "from", "the", "sale", "of", "stock", "to", "LPC", "and", "pursuant", "to", "the", "ATM."], "wordsB": ["Despite", "the", "capacity", "remaining", "under", "our", "registration", "statement", "and", "the", "remaining", "amounts", "available", "under", "our", "ATM", "and", "LPC", "Purchase", "Agreement,", "pursuant", "to", "Instruction", "I.B.6", "to", "Form", "S-3,", "we", "may", "not", "sell", "more", "than", "the", "equivalent", "of", "one-third", "of", "our", "public", "float", "during", "any", "12", "consecutive", "months", "so", "long", "as", "our", "public", "float", "is", "less", "than", "$75", "million,", "which", "will", "limit", "our", "ability", "to", "raise", "funds", "using", "those", "facilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p58_s1", "idA": "1316175_16_item7_p90_s0", "sentA": "The above amounts exclude potential payments to be made under our license agreements to our licensors that are based on the progress of our product candidates in development, as these payments are not determinable.", "sentB": "Financial instruments such as warrants that are evaluated to be classified as liabilities are fair valued upon issuance and are remeasured at fair value at subsequent reporting periods with the resulting change in fair value recorded in other income/(expense).", "type": 1, "words": ["<tag1>", "The", "above", "amounts", "exclude", "potential", "payments", "to", "be", "made", "under", "our", "license", "agreements", "to", "our", "licensors", "that", "are", "based", "on", "the", "progress", "of", "our", "product", "candidates", "in", "development,", "as", "these", "payments", "are", "not", "determinable.", "<tag2>", "Financial", "instruments", "such", "as", "warrants", "that", "are", "evaluated", "to", "be", "classified", "as", "liabilities", "are", "fair", "valued", "upon", "issuance", "and", "are", "remeasured", "at", "fair", "value", "at", "subsequent", "reporting", "periods", "with", "the", "resulting", "change", "in", "fair", "value", "recorded", "in", "other", "income/(expense).", "<tag3>"], "wordsA": ["The", "above", "amounts", "exclude", "potential", "payments", "to", "be", "made", "under", "our", "license", "agreements", "to", "our", "licensors", "that", "are", "based", "on", "the", "progress", "of", "our", "product", "candidates", "in", "development,", "as", "these", "payments", "are", "not", "determinable."], "wordsB": ["Financial", "instruments", "such", "as", "warrants", "that", "are", "evaluated", "to", "be", "classified", "as", "liabilities", "are", "fair", "valued", "upon", "issuance", "and", "are", "remeasured", "at", "fair", "value", "at", "subsequent", "reporting", "periods", "with", "the", "resulting", "change", "in", "fair", "value", "recorded", "in", "other", "income/(expense)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p112_s8", "idA": "1316175_16_item7_p99_s1", "sentA": "In addition, the terms of any financing may adversely affect the holdings or the rights of our stockholders.", "sentB": "Failure to generate revenue or raise additional capital would adversely affect our ability to achieve its intended business objectives.", "type": 1, "words": ["<tag1>", "In", "addition,", "the", "terms", "of", "any", "financing", "may", "adversely", "affect", "the", "holdings", "or", "the", "rights", "of", "our", "stockholders.", "<tag2>", "Failure", "to", "generate", "revenue", "or", "raise", "additional", "capital", "would", "adversely", "affect", "our", "ability", "to", "achieve", "its", "intended", "business", "objectives.", "<tag3>"], "wordsA": ["In", "addition,", "the", "terms", "of", "any", "financing", "may", "adversely", "affect", "the", "holdings", "or", "the", "rights", "of", "our", "stockholders."], "wordsB": ["Failure", "to", "generate", "revenue", "or", "raise", "additional", "capital", "would", "adversely", "affect", "our", "ability", "to", "achieve", "its", "intended", "business", "objectives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_17_item7_p93_s4", "idA": "1316175_16_item7_p99_s1", "sentA": "In addition, the terms of any financing may adversely affect the holdings or the rights of our stockholders.", "sentB": "Failure to generate revenue or raise additional capital would adversely affect our ability to achieve our intended business objectives.", "type": 1, "words": ["<tag1>", "In", "addition,", "the", "terms", "of", "any", "financing", "may", "adversely", "affect", "the", "holdings", "or", "the", "rights", "of", "our", "stockholders.", "<tag2>", "Failure", "to", "generate", "revenue", "or", "raise", "additional", "capital", "would", "adversely", "affect", "our", "ability", "to", "achieve", "our", "intended", "business", "objectives.", "<tag3>"], "wordsA": ["In", "addition,", "the", "terms", "of", "any", "financing", "may", "adversely", "affect", "the", "holdings", "or", "the", "rights", "of", "our", "stockholders."], "wordsB": ["Failure", "to", "generate", "revenue", "or", "raise", "additional", "capital", "would", "adversely", "affect", "our", "ability", "to", "achieve", "our", "intended", "business", "objectives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p19_s9", "idA": "1316175_17_item7_p12_s0", "sentA": "We initiated the Phase 3 SOLUTION study in the third quarter of 2015.", "sentB": "m 2 with placebo as seen in the graph below.", "type": 1, "words": ["<tag1>", "We", "initiated", "the", "Phase", "3", "SOLUTION", "study", "in", "the", "third", "quarter", "of", "2015.", "<tag2>", "m", "2", "with", "placebo", "as", "seen", "in", "the", "graph", "below.", "<tag3>"], "wordsA": ["We", "initiated", "the", "Phase", "3", "SOLUTION", "study", "in", "the", "third", "quarter", "of", "2015."], "wordsB": ["m", "2", "with", "placebo", "as", "seen", "in", "the", "graph", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p86_s3", "idA": "1316175_17_item7_p16_s3", "sentA": "Based on the learning from the SOLUTION study, we plans to amend the SIMPLICITY study to follow similar dosing approach as the RESULT study.", "sentB": "If the RESULT study meets its primary endpoint, the Company plans to raise sufficient capital following the study s readout and use the proceeds to fund the preparation of its Biologics License Application ( BLA ) for Sollpura, continuation of its manufacturing of drug products and general corporate purpose.", "type": 1, "words": ["<tag1>", "Based", "on", "the", "learning", "from", "the", "SOLUTION", "study,", "we", "plans", "to", "amend", "the", "SIMPLICITY", "study", "to", "follow", "similar", "dosing", "approach", "as", "the", "RESULT", "study.", "<tag2>", "If", "the", "RESULT", "study", "meets", "its", "primary", "endpoint,", "the", "Company", "plans", "to", "raise", "sufficient", "capital", "following", "the", "study", "s", "readout", "and", "use", "the", "proceeds", "to", "fund", "the", "preparation", "of", "its", "Biologics", "License", "Application", "(", "BLA", ")", "for", "Sollpura,", "continuation", "of", "its", "manufacturing", "of", "drug", "products", "and", "general", "corporate", "purpose.", "<tag3>"], "wordsA": ["Based", "on", "the", "learning", "from", "the", "SOLUTION", "study,", "we", "plans", "to", "amend", "the", "SIMPLICITY", "study", "to", "follow", "similar", "dosing", "approach", "as", "the", "RESULT", "study."], "wordsB": ["If", "the", "RESULT", "study", "meets", "its", "primary", "endpoint,", "the", "Company", "plans", "to", "raise", "sufficient", "capital", "following", "the", "study", "s", "readout", "and", "use", "the", "proceeds", "to", "fund", "the", "preparation", "of", "its", "Biologics", "License", "Application", "(", "BLA", ")", "for", "Sollpura,", "continuation", "of", "its", "manufacturing", "of", "drug", "products", "and", "general", "corporate", "purpose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p11_s3", "idA": "1316175_17_item7_p17_s1", "sentA": "We plan to modif y this study to allow patients completing future studies (e.g., RESULT or SIMPLICITY Part B) to have continued access until the BLA for Sollpura is approved by the FDA.", "sentB": "Patients are then followed in a 20-week extension period for the collection of longer term safety and efficacy (e.g., growth, maintenance of body weight) data.", "type": 1, "words": ["<tag1>", "We", "plan", "to", "modif", "y", "this", "study", "to", "allow", "patients", "completing", "future", "studies", "(e.g.,", "RESULT", "or", "SIMPLICITY", "Part", "B)", "to", "have", "continued", "access", "until", "the", "BLA", "for", "Sollpura", "is", "approved", "by", "the", "FDA.", "<tag2>", "Patients", "are", "then", "followed", "in", "a", "20-week", "extension", "period", "for", "the", "collection", "of", "longer", "term", "safety", "and", "efficacy", "(e.g.,", "growth,", "maintenance", "of", "body", "weight)", "data.", "<tag3>"], "wordsA": ["We", "plan", "to", "modif", "y", "this", "study", "to", "allow", "patients", "completing", "future", "studies", "(e.g.,", "RESULT", "or", "SIMPLICITY", "Part", "B)", "to", "have", "continued", "access", "until", "the", "BLA", "for", "Sollpura", "is", "approved", "by", "the", "FDA."], "wordsB": ["Patients", "are", "then", "followed", "in", "a", "20-week", "extension", "period", "for", "the", "collection", "of", "longer", "term", "safety", "and", "efficacy", "(e.g.,", "growth,", "maintenance", "of", "body", "weight)", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p19_s8", "idA": "1316175_17_item7_p27_s1", "sentA": "While the numerical reduction in proteinuria in blisibimod versus placebo treated patients at week 24 did not meet the predefined statistical primary endpoint of complete or partial response, longer-term data from the study demonstrated an increasingly large separation in proteinuria favoring the blisibimod treated arm compared to the placebo.", "sentB": "Specifically, in patients treated with blisibimod, the mean change in proteinuria was stable to trending slightly downward, whereas the mean levels increased for patients in the placebo arm.", "type": 1, "words": ["<tag1>", "While", "the", "numerical", "reduction", "in", "proteinuria", "in", "blisibimod", "versus", "placebo", "treated", "patients", "at", "week", "24", "did", "not", "meet", "the", "predefined", "statistical", "primary", "endpoint", "of", "complete", "or", "partial", "response,", "longer-term", "data", "from", "the", "study", "demonstrated", "an", "increasingly", "large", "separation", "in", "proteinuria", "favoring", "the", "blisibimod", "treated", "arm", "compared", "to", "the", "placebo.", "<tag2>", "Specifically,", "in", "patients", "treated", "with", "blisibimod,", "the", "mean", "change", "in", "proteinuria", "was", "stable", "to", "trending", "slightly", "downward,", "whereas", "the", "mean", "levels", "increased", "for", "patients", "in", "the", "placebo", "arm.", "<tag3>"], "wordsA": ["While", "the", "numerical", "reduction", "in", "proteinuria", "in", "blisibimod", "versus", "placebo", "treated", "patients", "at", "week", "24", "did", "not", "meet", "the", "predefined", "statistical", "primary", "endpoint", "of", "complete", "or", "partial", "response,", "longer-term", "data", "from", "the", "study", "demonstrated", "an", "increasingly", "large", "separation", "in", "proteinuria", "favoring", "the", "blisibimod", "treated", "arm", "compared", "to", "the", "placebo."], "wordsB": ["Specifically,", "in", "patients", "treated", "with", "blisibimod,", "the", "mean", "change", "in", "proteinuria", "was", "stable", "to", "trending", "slightly", "downward,", "whereas", "the", "mean", "levels", "increased", "for", "patients", "in", "the", "placebo", "arm."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p71_s0", "idA": "1316175_17_item7_p4_s0", "sentA": "Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.", "sentB": "The CHABLIS studies enrolled more than 400 patients with systemic lupus erythematous ( SLE ) across multiple geographies in Asia, Europe and Latin America.", "type": 1, "words": ["<tag1>", "Anthera", "Pharmaceuticals,", "Inc.", "is", "a", "biopharmaceutical", "company", "focused", "on", "advancing", "the", "development", "and", "commercialization", "of", "innovative", "medicines", "that", "benefit", "patients", "with", "unmet", "medical", "needs.", "<tag2>", "The", "CHABLIS", "studies", "enrolled", "more", "than", "400", "patients", "with", "systemic", "lupus", "erythematous", "(", "SLE", ")", "across", "multiple", "geographies", "in", "Asia,", "Europe", "and", "Latin", "America.", "<tag3>"], "wordsA": ["Anthera", "Pharmaceuticals,", "Inc.", "is", "a", "biopharmaceutical", "company", "focused", "on", "advancing", "the", "development", "and", "commercialization", "of", "innovative", "medicines", "that", "benefit", "patients", "with", "unmet", "medical", "needs."], "wordsB": ["The", "CHABLIS", "studies", "enrolled", "more", "than", "400", "patients", "with", "systemic", "lupus", "erythematous", "(", "SLE", ")", "across", "multiple", "geographies", "in", "Asia,", "Europe", "and", "Latin", "America."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p11_s5", "idA": "1316175_17_item7_p86_s1", "sentA": "No further investments were made by the investors and the right for Additional Investment expired on January 26, 2017.", "sentB": "Furthermore, the study had been approved by the Cystic Fibrosis Foundation Therapeutics Development Network ( CFFTDN ) Protocol Review Committee, and the European Cystic Fibrosis Society Clinical Trial Network Executive Committee.", "type": 1, "words": ["<tag1>", "No", "further", "investments", "were", "made", "by", "the", "investors", "and", "the", "right", "for", "Additional", "Investment", "expired", "on", "January", "26,", "2017.", "<tag2>", "Furthermore,", "the", "study", "had", "been", "approved", "by", "the", "Cystic", "Fibrosis", "Foundation", "Therapeutics", "Development", "Network", "(", "CFFTDN", ")", "Protocol", "Review", "Committee,", "and", "the", "European", "Cystic", "Fibrosis", "Society", "Clinical", "Trial", "Network", "Executive", "Committee.", "<tag3>"], "wordsA": ["No", "further", "investments", "were", "made", "by", "the", "investors", "and", "the", "right", "for", "Additional", "Investment", "expired", "on", "January", "26,", "2017."], "wordsB": ["Furthermore,", "the", "study", "had", "been", "approved", "by", "the", "Cystic", "Fibrosis", "Foundation", "Therapeutics", "Development", "Network", "(", "CFFTDN", ")", "Protocol", "Review", "Committee,", "and", "the", "European", "Cystic", "Fibrosis", "Society", "Clinical", "Trial", "Network", "Executive", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p19_s7", "idA": "1316175_17_item7_p86_s1", "sentA": "No further investments were made by the investors and the right for Additional Investment expired on January 26, 2017.", "sentB": "Throughout the treatment period and for up to one year of additional follow up off treatment, blisibimod appeared to halt disease progression as measured by the mean estimate of urinary protein:creatinine levels (\"proteinuria\").", "type": 1, "words": ["<tag1>", "No", "further", "investments", "were", "made", "by", "the", "investors", "and", "the", "right", "for", "Additional", "Investment", "expired", "on", "January", "26,", "2017.", "<tag2>", "Throughout", "the", "treatment", "period", "and", "for", "up", "to", "one", "year", "of", "additional", "follow", "up", "off", "treatment,", "blisibimod", "appeared", "to", "halt", "disease", "progression", "as", "measured", "by", "the", "mean", "estimate", "of", "urinary", "protein:creatinine", "levels", "(\"proteinuria\").", "<tag3>"], "wordsA": ["No", "further", "investments", "were", "made", "by", "the", "investors", "and", "the", "right", "for", "Additional", "Investment", "expired", "on", "January", "26,", "2017."], "wordsB": ["Throughout", "the", "treatment", "period", "and", "for", "up", "to", "one", "year", "of", "additional", "follow", "up", "off", "treatment,", "blisibimod", "appeared", "to", "halt", "disease", "progression", "as", "measured", "by", "the", "mean", "estimate", "of", "urinary", "protein:creatinine", "levels", "(\"proteinuria\")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1316175_18_item7_p79_s0", "idA": "1316175_17_item7_p90_s2", "sentA": "On March 14, 2017, we amended the H.C. Wainwright ATM Agreement and reduced the amount registered under the registration statement to $23 million.", "sentB": "In February 2018, the Company early terminated the lease agreement for its Pleasanton office and reduced its future lease payment by approximately $42,000.", "type": 1, "words": ["<tag1>", "On", "March", "14,", "2017,", "we", "amended", "the", "H.C.", "Wainwright", "ATM", "Agreement", "and", "reduced", "the", "amount", "registered", "under", "the", "registration", "statement", "to", "$23", "million.", "<tag2>", "In", "February", "2018,", "the", "Company", "early", "terminated", "the", "lease", "agreement", "for", "its", "Pleasanton", "office", "and", "reduced", "its", "future", "lease", "payment", "by", "approximately", "$42,000.", "<tag3>"], "wordsA": ["On", "March", "14,", "2017,", "we", "amended", "the", "H.C.", "Wainwright", "ATM", "Agreement", "and", "reduced", "the", "amount", "registered", "under", "the", "registration", "statement", "to", "$23", "million."], "wordsB": ["In", "February", "2018,", "the", "Company", "early", "terminated", "the", "lease", "agreement", "for", "its", "Pleasanton", "office", "and", "reduced", "its", "future", "lease", "payment", "by", "approximately", "$42,000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
